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CHAPTER I 
 
INTRODUCTION 
 
I: Bioenergetics and oxidative phosphorylation 
 Mitochondria, described as “the power plants” of cells are the site of eukaryotic 
oxidative phosphorylation.  This process is responsible for more than 95 % of the energy 
required, and is carried out in the inner mitochondrial membrane by electron transfer 
complexes and the ATP synthase complex (Fig 1).  The mitochondrial electron transport 
chain is composed of four multi-subunit electron transfer complexes: NADH-ubiquinone 
oxidoreductase, also called Complex I, succinate-ubiquinone reductase or Complex II,  
ubiquinol-cytochrome c reductase or Complex III, and cytochrome c oxidase also known 
as Complex IV.   
 NADH and succinate, derived from the TCA cycle and the β-oxidation of fatty 
acids and amino acids, are oxidized by NADH-ubiquinone oxidoreductase and succinate-
ubiquinone oxidoreductase respectively to form NAD+ and fumerate.  The electrons are 
then transferred to ubiquinol-cytochrome c reductase, cytochrome c oxidase and 
eventually to molecular oxygen.  Electron transfer through the complexes is coupled to 
proton translocation across the inner membrane in all complexes except succinate-
ubiquinone reductase.  This results in the generation of a membrane potential that is 
utilized by the ATP synthase to synthesize ATP.  ATP synthase is comprised of two  
 1
  
 
 
Figure 1.  Mitochondrial electron transport chain.  Electron transfer complexes are 
labeled as: Complex I, NADH-Q Oxidoreductase; Complex II, Succinate-Q 
Oxidoreductase; Complex III, Ubiquinol Cytochrome c Oxidoreductase; Complex IV, 
Cytochrome c Oxidase; Complex V, ATP synthase.  Electron flow is represented by 
black arrows while proton transfers are shown in red.  The reactions catalyzed by the 
individual complexes are indicated as well.     
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functional subunits; F0 and F1.  F1 is the water-soluble catalytic subunit that binds ADP 
and Pi to generate ATP.  It consists of a hexagonal array of alternating α and β subunits 
with a centrally located γ subunit that has been shown to rotate during catalysis (1-3).  
The detergent soluble F0 subunit is a hydrophobic trans-membrane protein that contains a 
proton translocation channel.  The ATP synthase operates through a mechanism in which 
three interacting catalytic protomers undergo a change in binding affinity for the 
reactants, ATP, ADP and inorganic phosphate (Pi).  The change in affinity for the 
reactants results in a change in the γ-subunit position relative to the α3β3 assembly, which 
involves a rotation of one relative to the other (2, 4).  The rotation of the α3β3 assembly 
of F1 is driven in the direction of ATP synthesis by an influx of H+ down the proton 
gradient to the matrix from the inter-membrane space.  The generation of a proton motive 
force across the energy-transducing membrane coupled to electron transfer is the central 
dogma of the chemiosmotic theory, proposed by Nobel laureate Peter Mitchell in 1961 
(5).    
 
II. The cytochrome bc1 complex 
1. Cytochrome bc1 complex and the electron transport chain. 
 The cytochrome bc1 complex, or ubiquinol-cytochrome c oxidoreductase, is an 
essential component of the energy-conserving, electron transfer chain of mitochondria 
and many respiratory and photosynthetic bacteria (6).  The complex catalyzes electron 
transfer from ubiquinol to cytochrome c with the concomitant translocation of protons the 
membrane to generate a proton gradient and membrane potential for ATP synthesis.     
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 The cytochrome bc1 complex from all species contains three core subunits that house four 
redox prosthetic groups: cytochrome b with heme bL (b566), and bH (b562), cytochrome c1, 
which houses a c-type heme, and a high potential iron sulfur cluster in the Rieske iron-
sulfur protein (ISP).  In addition to the three core subunits, varying numbers of non-redox 
group containing subunits called supernumerary subunits are present in the cytochrome 
bc1 complexes from different sources.  For example, cytochrome bc1 complexes from 
Rhodobacter capsulatus have no supernumerary subunits, Rhodobacter sphaeroides bc1 
complex has one, while complexes from bovine mitochondria have eight.  The exact role 
of supernumerary subunits is uncertain, but it has been reported that complexes without 
any supernumerary subunits are less stable and have lower activity (7, 8).     
 
2. The Q-cycle mechanism 
 The simplest arrangement for electron transfer via the cytochrome bc1 complex is 
a linear pathway, where the direction of electron transfer is determined by the redox 
potential of the various prosthetic groups as shown in the scheme below; 
 
                         QH2        bL        bH        ISP        cyt. c1        cyt. c  
 
However, this scheme fails to explain the 2 H+/e- stoichiometry observed in cytochrome 
bc1 complex catalysis (9), as it can only account for a 1 H+/e- stoichiometry.  This linear 
scheme of electron transfer also fails to explain the phenomenon described as ‘oxidant-
induced reduction of cytochrome b’ observed by Chance et. al. (10).  Addition of a pulse 
of oxygen to slowly respiring mitochondria, in the presence of antimycin A, resulted in a 
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 transient increase in cytochrome b reduction with a rate comparable to the oxidation of 
cytochrome c1.    
 Peter Mitchell was the first to propose the ‘Q-cycle mechanism’ (Fig. 2) to 
explain the electron and proton transfer mechanism within the cytochrome bc1 complex 
(11).  The ‘modified Q-cycle’ is now widely accepted as it adequately accounts for most 
of the experimental results mentioned above, including the ‘oxidant-induced reduction of 
cytochrome b’ (12-14).  There are two key features of the Q-cycle mechanism: (a) the 
presence of two separate binding sites for ubiquinol and ubiquinone, namely QP and QN 
sites, and (b) the bifurcated electron transfer at the QP site.  Ubiquinol is oxidized at the 
QP site with a relatively high activation barrier (13).  The first electron from ubiquinol 
oxidation is transferred to a high-potential chain consisting of the Rieske iron-sulfur 
protein, cytochrome c1 and cytochrome c.  Two protons are released into the inter-
membrane space.  The second electron is passed to a lower-potential chain containing the 
bL and bH hemes.  The electron then reduces a ubiquinone at the QN site to form a stable 
ubisemiquinone (Q.-).  At this juncture, only half of the Q-cycle is complete.  During the 
second turnover, a second ubiquinol is oxidized at the QP site, and the electron from heme 
bH now reduces the ubisemiquinone formed at the QN site during the first cycle.  
Subsequently, two protons are taken up from the N-side to form QH2 thereby completing 
one Q-cycle.  The end result of one complete Q-cycle is the oxidation of two ubiquinol 
molecules at the QP site, the generation of one ubiquinol molecule at the QN site, the 
production of two molecules of reduced cytochrome c, and the deposition of four protons 
on the P-side of the membrane.  The overall Q-cycle reaction is represented by the 
equation below;  
 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The protonmotive Q-cycle mechanism of electron transfer and proton 
translocation in the cytochrome bc1 complex.  The QP and QN sites are represented by 
dashed circles and labeled as Center P and Center N respectively.  The sites of action of 
myxothiazol, a Class Ia inhibitor and antimycin A are shown in red.  Electron transfer 
pathways are shown by white arrows while protons are shown in yellow block arrows.   
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tential pathway is available.  Several models on the bifurcated electron transfer at 
ite have been proposed.  The sequential (15-17) and the concerted mechanism 
are the widely accepted views on ubiquinol oxidation at the QP site.  In the 
d mechanism, an electron from ubiquinol is transferred to heme bL at or about the 
e an electron is transferred to ISP.  This mechanism excludes the generation of a 
quinone radical at the QP site.  In the sequential mechanism, a ubisemiquinone 
ormed after reduction of the high-potential chain reduces heme bL and the low-
l pathway.  However, the existence of such a radical has not been detected yet 
ggestions have been made that a relatively stable complex of ISPred with 
quinone might be formed, but both their EPR signals might be lost through 
on between their neighboring spins (18).   
hree-Dimensional Crystal Structure of the Cytochrome bc1 Complex              
verall structure of the Cytochrome bc1 complex. 
hree-dimensional structures of mitochondrial bc1 complexes from bovine (22, 
chicken (24) were determined by X-ray diffraction of crystals at 3 Å.  The first 
me bc1 complex crystal structure, determined at 2.9 Å was reported by our group  
7
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Figure 3.  The 3-D structure of the dimeric mitochondrial cytochrome bc1 complex.  
The color code for each subunit is given on the side bar.  Prosthetic groups are shown in 
ball-and-stick model.  The two parallel lines indicate the membrane-spanning regions.  
The mitochondrial inter-membrane space (IMS), the membrane spanning region (TM), 
and the matrix are as labeled. 
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 in 1997 in collaboration with Dr. Deisenhofer’s lab at Southwest Medical Center in 
Dallas, Texas (22).  The resolutions were later improved to 2.31 Å using cytochrome bc1 
complex purified from yeast crystallized in the presence of a monoclonal antibody Fv 
fragment (25).  The structure of the cytochrome b6f complex, a complex that is analogous 
to the cytochrome bc1 complex, that provides an electronic connection between 
photosystems I and II, has also been established for the thermophillic cyanobacterium 
(blue-green algae) Mastigocladus laminosus (26) and in the algae Chlamydomonas 
reinhardtii (27).  In our bovine I4122 crystal structure, the cytochrome bc1 complex is a 
pear-shaped intertwined dimer with a diameter of 130 Å at its widest point in the matrix, 
and is 155 Å in height.  It can be divided into three regions: matrix, transmembrane, and 
the inter-membrane space regions (Fig. 3).  The majority of the complex is located in the 
matrix region, extending 75 Å deep.  This region consists of subunits I, II, VI, IX, the N-
terminal part of subunit VII and the C-terminal of ISP.  The transmembrane region is 
approximately 42 Å, and consists of thirteen transmembrane helices in each monomer, 
eight from cytochrome b, one each from cytochrome c1, ISP, subunits VII, X, and XI.  
The transmembrane region of cytochrome b houses hemes bL and bH, and the two 
ubiquinol binding sites, QP and QN.  The inter-membrane space region, 38 Å tall, houses 
heme c1 and the Rieske iron-sulfur cluster.   
 In native crystals, a bound ubiquinone molecule that occupies the same region as 
antimycin A has been described (25, 35).  However, no ubiquinol / ubiquinone 
molecule(s) have been identified at the QP inhibitor binding site.  Therefore, any 
discussions on the mechanisms of electron transfer are based primarily on the positions 
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 occupied by inhibitors at the QP site, and assumptions are made to reflect a similar site for 
binding of the natural substrate, ubiquinol.   
    B. The structure of the Rieske iron-sulfur protein (ISP)  
 The presence of an iron-sulfur cluster in the bc1 complex was first recognized by 
its contribution to the EPR spectrum (28).  The structure of the Rieske iron-sulfur protein 
(Fig 4) is divided into three domains: the membrane-spanning N-terminal domain (tail) 
including residues 1-62, the soluble C-terminal domain (head) covering residues 73-96, 
and the flexible domain that links the head and tail domains containing residues 63-72 
(29).  The soluble, extra-membrane head domain of ISP from bovine heart containing the 
intact iron-sulfur cluster was crystallized and its structure determined at 1.5 Å (29).  It is 
a rigid, compact, and flat-spherical shaped structure containing three layers of anti-
parallel β-sheets composed of ten β-strands.  Unlike classical ferrodoxin-type [2Fe-2S] 
centers where the ligands are all cysteines, the [2Fe-2S] cluster of the Rieske ISP is 
coordinated by two cysteine and two histidine residues.  Loops β4-β5 and β6-β7, each 
contributes one cysteine and one histidine residue.  An additional cysteine residue is 
present in each loop, forming a disulfide bond connecting the two loops contributing to 
the stability of the protein.  A complex salt bridge and hydrogen-bond network exists, 
which further stabilizes the protein.  Multiple factors contribute to the high redox 
potential of the cluster: the overall charge of the cluster, 0 and -1 for the oxidized and 
reduced state, respectively, compared with -2 and -3 for [2Fe-2S] clusters with four 
cysteine coordination in ferrodoxins; the electronegativity of the histidine ligands and the 
solvent exposure of the Fe(II).  The transmembrane helix of ISP is in one monomer while 
its extrinsic domain crosses over and associates with cytochrome b and c1 of the other 
 10
  
Figure 4.  Structure of the Rieske iron-sulfur protein (ISP).  The overall structure of 
ISP (A), the ligands of the Rieske iron-sulfur cluster (B), and the salt bridge / hydrogen 
bond network around the iron-sulfur cluster (C).  The head, neck and tail domains of the 
Rieske ISP are shown. 
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 monomer.  Therefore, the bc1 complex is a functional dimer, since dimerization is 
necessary to complete the high-potential chain consisting of the Rieske ISP and 
cytochrome c1.  A functional unit of bc1 complex consists of cytochromes b and c1 from 
one monomer, and a Rieske ISP from the other monomer. 
 
C.  Structure of cytochrome b 
 
 Cytochrome b is the only mitochondrially encoded protein in the cytochrome bc1 
complex.  It has eight trans-membrane helices designated with capital letters A-H, and 
the linker regions are labeled with lower case letters (Fig 5).  The trans-membrane 
regions can be divided into two groups; helices A-E in one group and F-H in the other.  
The crystal structures indicate that both the N- and C- terminals are located in the matrix 
region.  The high-potential heme (bH) is close to the matrix side of the cytochrome b 
subunit, while the low potential-heme (bL) lies close to the exterior surface of the subunit, 
but is shielded from the aqueous phase by cytochrome c1.  The iron-iron distance between 
the high-potential and low-potential hemes is 20.7 Å, and is in good agreement with the 
predicted distance of 22 Å derived from biochemical and biophysical studies (30).  The 
low potential hemes in the two monomers are quite close; the distance between the two 
irons is 21.2 Å, and electron transfer between the two monomers via the two heme bL’s 
has been reported (31).  Histidines serve as the axial ligands for both the low and high-
potential hemes.  His- 83 and His-182 co-ordinate heme bL while that role is fulfilled by 
His-97 and His-196 in heme bH.  The putative ubiquinol / ubiquinone binding sites, QP 
and QN, are located at the P-side and the N-side, and in close vicinity of hemes bL and bH 
respectively. 
 12
  
 
   
Figure 5.  Structure of the mitochondrial cytochrome b subunit.  Ribbon 
representation of cyt b showing its eight trans-membrane helices.  Hemes bL and bH are 
shown as stick models with carbon atoms in yellow, nitrogen blue and oxygen red.  The 
helices are individually labeled, and the loops connecting the helices are also shown. 
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  D.  Crystal Structure of the cytochrome bc1 complex loaded with inhibitors 
 Historically, cytochrome bc1 complex inhibitors were divided into two classes 
depending upon their site of action.  Class I inhibitors bind at the QP site while Class II 
inhibitors bind at the QN site (32-34).  The Class I inhibitors were further divided into 
sub-groups based upon the chemical characteristics of the inhibitors, and on biophysical 
and spectroscopic effects of the bL heme and the iron-sulfur cluster upon binding of 
inhibitors.  Class Ia inhibitors include myxothiazol and β-methoxyacrylate stilbene 
(MOAS); they presumably block electron transfer from quinol to the ISP accompanying a 
red-shift in the α and β-bands of the reduced cytochrome b.  Class Ib inhibitors possess a 
chromone ring system, and inhibit electron transfer from ISP to cytochrome c1.  A 
pronounced increase in the redox potential of the ISP is observed upon binding of Class 
Ib inhibitors.  Like the Class Ia inhibitors, Class Ib inhibitors cause a red-shift in the 
absorption spectrum of reduced cytochrome b.  Stigmatellin is an example of a Class Ib 
inhibitor. 
   It was recognized in the first bc1 complex structures that the extrinsic head 
domain of ISP was highly mobile (22).  It was further demonstrated that, when the 
soluble head domain of ISP is not restricted in motion by crystallographic contacts, it 
assumes one of two states in response to binding of different Class I inhibitors: a fixed or 
mobile state (35-37).  In the crystals of native cytochrome bc1 complex (i.e. QP site 
empty), the soluble head domains are partitioned between a fixed and loose state.  The 
binding of Class Ib inhibitors, or ‘PF’ inhibitors like stigmatellin and UHDBT, results in 
the ISP head in the fixed state, while Class Ia or ‘PM’ inhibitors exhibit a dramatic 
increase in the mobility.  The binding of QP site inhibitors has a considerable effect on the 
 14
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.  Chemical structures of some cytochrome bc1 complex inhibitors. 
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Table 1 
Effects of QP site inhibitors on the relative anomalous peak heights of the [2Fe-2S] 
cluster of the ISP normalized to the heme bH peak  
Crystal preparation        Normalized peak heights a
Native bc1 (QP binding pocket empty) 0.52 
+ MOAS 0.23 
+ Myxothiazol 0.46 
+ Azoxystrobin 0.36 
+ Stigmatellin 1.20 
+UHDBT 0.96 
+ Fomaxodone 1.02 
 
a Peaks are normalized against anomalous signals of their respective bH heme irons. 
 16
 electron density of the anomalous scattering of the FeS peak heights (38).  All iron 
anomalous peaks were normalized by the peak height of the bH heme iron, and the values 
in the presence of different inhibitors are presented in Table 1.  The use of the bH heme 
peak as an internal standard is justified because of the structural stability of the heme 
environment due to its proximity to the core proteins of the bc1 complex where most of 
the crystal contacts are made.  Binding of Class Ib inhibitors like stigmatellin or UHDBT 
enhances the electron density of the anomalous scattering peak of the [2Fe-2S] cluster, 
while Class Ia inhibitors like myxothiazol and MOAS abolish the electron density. 
 Conformational variations in cytochrome b upon binding of PF inhibitors are 
limited to a few regions: the inhibitor binding sites, the ISP neck contact area, and parts 
of the ef loop (35).  Alignment of inhibitor-bound structures with the native bc1 structure 
reveals complexity both in terms of magnitude and the direction of displacement of 
certain amino acid residues.  Antimycin A binding to the bc1 complex does not induce 
significant conformational change in cytochrome b residues, except for small 
displacements of 0.5 – 1 Å to facilitate the binding of the inhibitor (36).  However, the 
binding of stigmatellin led to significant conformational changes, particularly in the cd-1 
and cd-2 helices and the ef loop.  The hydroxyl group of stigmatellin forms a hydrogen 
bond with Glu-271 whose side-chain has rotated 160o from the inhibitor-free state.  
Displacement vectors, measured between Cα atoms of inhibitor bound and native 
structures for residues that are in direct contact with the PF and PM inhibitors are given in 
Tables 2A, and 3 respectively (38).  
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 Table 2 
Displacement vector (Vd) length for residues of cyt. b upon inhibitor binding.  
 
 
           
   
Cyt. b  Myxothiazol     MOAS Azoxystrobin  
residue 
 
M124 0.49 0.26 0.25 
F128 0.29 0.19 0.15 
Y131 0.40 0.34 0.51 
V132 0.27 0.13 0.38 
M138 0.20 0.26 0.33 
G142 0.49 0.42 0.48 
A143 0.42 0.20 0.43 
V145 0.39 0.32 0.49 
I146 0.45 0.51 0.65 
I268 0.94 0.55 0.72 
P270 1.29 1.23 1.51 
E271 1.15 1.23 1.52 
Y273 0.39 0.24 0.53 
F274 0.43 0.18 0.57 
Y278 0.47 0.43 0.66 
L294 0.69 0.53 0.71 
I298 0.23 0.49 0.89  
Cyt. b  Fomaxodone Stigmatellin UHDBT NQNO 
residue 
 
M124 0.37 0.43 0.35 0.26 
F128 0.37 0.41 0.60 0.36 
Y131 0.28 0.18 0.42 0.28 
V132 0.11 0.20 0.29 0.25 
M138 0.27 0.57 1.06 0.66 
G142 0.23 1.31 1.20 0.75 
A143 0.17 1.16 1.05 0.60 
V145 0.68 1.41 1.40 1.06 
I146 0.69 1.33 1.37 0.98 
I268 0.75 1.16 0.84 0.25 
P270 1.56 1.19 0.46 0.61 
E271 1.21 0.77 0.32 0.54 
Y273 0.61 0.52 0.20 0.25 
F274 0.47 0.51 0.48 0.17 
Y278 0.25 0.13 0.63 0.36 
L294 0.22 0.28 0.24 0.24 
I298 0.24 0.20 0.27 0.26 
A 
B 
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 4. Study System 
 The photosynthetic bacterium, Rhodobacter sphaeroides is used as the model 
system for our studies.  R. sphaeroides is an anoxygenic purple facultative bacterium.  In 
plants and algae, photosynthesis occurs in an aerobic environment resulting in the release 
of oxygen as a result of the water splitting process.  However, in R. sphaeroides, 
photosynthesis occurs in an anaerobic environment, and does not result in the production 
of oxygen.  The synthesis of some photosynthetic pigments in R. sphaeroides is actually 
repressed by oxygen (40).  The preferred growth mode of R. sphaeroides is 
photoheterotrophic, under anaerobic conditions in light with various organic substrates.  
The ecological niches of R. sphaeroides are anoxic parts of waters and sediments, which 
receive light of sufficient quantity and quality to allow phototrophic development (40).     
 In R. sphaeroides, ATP is synthesized either via the cyclic or non-cyclic electron 
transfer pathway (Fig 7).  The cyclic electron transfer pathway involves two membrane-
bound components; the reaction center (RC) where the initial light-dependant electron 
transfer occurs, and the cytochrome bc1 complex.  Upon excitation by light energy, P870, a 
bacteriochlorophyll inside the photosynthetic reaction center, becomes a strong reducing 
agent.  It transfers its electron to a second bacteriochlorophyll, a bacteriopheophytin, a 
bound quinone at site QA, and eventually to a bound quinone at QB.  Upon reduction by 
two electrons, the quinone at the site QB becomes fully reduced as Q2-, and two protons 
are taken up from the cytoplasm to form QH2 (41).  The QH2 leaves the RC and diffuses 
through the membrane towards the cytochrome bc1 complex, which in turn transfers the 
electrons to cytochrome c2.  As in the mitochondrion, four protons are translocated across 
the membrane for every two electrons that pass through the bc1 complex.  The reduced  
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Figure 7.  Electron transfer pathways in Rhodobacter sphaeroides.  Cyclic electron 
transfer in R. sphaeroides is shown enclosed within the red circle, while non-cyclic 
electron transfer is depicted by the gray block arrow.   
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 cytochrome c2 then transfers its electron back to the reaction center where it reduces P870.  
As a result of this cyclic electron transfer, there is no need for an exogenous electron 
donor or a terminal electron acceptor, and continuous synthesis of ATP is made possible.   
 R. sphaeroides is not a strict anaerobe.  When the oxygen tension is high, R. 
sphaeroides can also undergo respiratory growth.  Under these conditions, the 
photosynthetic apparatus is repressed, and there is an increase in the content of quinol 
oxidases.  A very important feature and advantage of using R. sphaeroides is that the bc1 
complex is not essential for aerobic growth by the non-cyclic pathway.  Under these 
conditions, the electrons can be transferred to oxygen by the aforementioned quinol 
oxidases.  Under aerobic growth, the synthesis of bacteriochlorophyll is repressed, 
resulting in a brownish / pink cell-culture rather than the brownish-green color observed 
in photosynthetically-grown cells.         
   The use of R. sphaeroides as model system for our studies of the cytochrome bc1 
complex has several advantages.   
1. Simplicity – The cytochrome bc1 complex from R. sphaeroides contains only four 
subunits; the three core subunits and one supernumerary subunit.  The three core 
subunits, i.e. cytochrome b, cytochrome c1 and ISP are homologous to their 
mitochondrial counterparts.    
2. Readily applied molecular engineering protocols – In eukaryotes, cytochrome b is 
encoded in the mitochondrion and is hence inconvenient for site-directed 
mutagenesis.  In R. sphaeroides, the three catalytic core subunits are encoded by 
genes organized in an fbcFBC operon.  This operon has been deleted from the 
chromosome in order to facilitate the mutagenic studies. 
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 3.   Mutant cytochrome bc1 complexes incapable of supporting photosynthetic 
growth can still be purified and characterized.  R. sphaeroides strains over-
expressing the defective cytochrome bc1 complexes can be grown in semi-aerobic 
conditions in the dark to induce extensive intra-cytoplasmic membrane (ICM) 
generation (42 - 44).   
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ABSTRACT 
Destruction of the Rieske iron-sulfur cluster ([2Fe-2S]) in the bc1 complex by 
hematoporphyrin-promoted photo-inactivation results in the complex becoming proton-
permeable (Miki, T., Yu, L., and Yu, C, -A. (1991) Biochemistry 30, 230-238).  To 
further study the role of this [2Fe-2S] cluster in proton translocation of the bc1 complex, 
Rhodobacter sphaeroides mutants expressing His-tagged cytochrome bc1 complexes 
with mutations at the histidine ligands of the [2Fe-2S] cluster were generated and 
characterized.  These mutants lack the [2Fe-2S] cluster and possess no bc1 activity.  
When the mutant complex is co-inlaid in phospholipid vesicles with intact bovine 
mitochondrial bc1 complex or cytochrome c oxidase, the proton ejection, normally 
observed in intact reductase or oxidase vesicles during the oxidation of their 
corresponding substrates, disappears.  This indicates the creation of a proton-leaking 
channel in the mutant complex, whose [2Fe-2S] cluster is lacking.  Insertion of bc1 
complex lacking the head domain of ISP, removed by thermolysin digestion, into PL 
vesicles together with mitochondrial bc1 complex also renders the vesicles proton-
permeable.  Addition of excess purified head domain of ISP partially restores proton-
pumping activity.  These results indicate that elimination of the [2Fe-2S] cluster in 
mutant bc1 complexes opens up an otherwise closed proton-channel within the bc1 
complex.  It is speculated that in the normal catalytic cycle of the bc1 complex, the [2Fe-
2S] cluster may function as a proton-exiting gate. 
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 INTRODUCTION 
The cytochrome bc1 complex, also known as ubiquinol-cytochrome c reductase or 
Complex III is the central segment of the energy conserving, electron transfer chain of 
mitochondria and many respiratory and photosynthetic bacteria (1).  This enzyme 
complex catalyzes electron transfer from ubiquinol to cytochrome c (c2 in bacteria) with 
concomitant translocation of protons across the membrane to generate a proton 
electrochemical gradient required for ATP synthesis by ATP synthase.  The cytochrome 
bc1 complexes from all species contain three core subunits, cytochrome b, cytochrome c1 
and Rieske Iron-Sulfur protein (ISP), that house two b type cytochromes (b566 and b562), 
one c-type cytochrome (c1) and a high potential Rieske [2Fe-2S] cluster respectively.  
However, the number of non-redox group containing subunits, also called supernumerary 
subunits, in the complex varies from species to species. 
 Recently the 3-D crystal structures of mitochondrial bc1 complexes from bovine 
(2, 3), chicken (4) and yeast (5), which contain seven to eight supernumerary subunits in 
addition to the three core subunits, have been obtained.  The structures of the cytochrome 
b6f complex, a complex analogous to the cytochrome bc1 complex that provides an 
electronic connection between photosystems I and II, have also been established for the 
thermophilic cyanobacterium Mastigocladus laminosus (6), and in the algae, 
Chlamydomonas reinhardtii (7), respectively.  The 3-D structural information for the 
mitochondrial bc1 complex establishes the location of the redox centers, the number of 
transmembrane helices, quinone binding at the QN site, and inhibitor binding at both the 
QP and QN sites (2-4, 8, 9).  Moreover, it suggests mobility of the extrinsic head domain 
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 of ISP during bc1 catalysis.  Strong evidence in support of this movement has been 
reported (10-19).   
The proton-motive Q-cycle model (20, 21) has been favored for describing 
electron and proton translocation in the cytochrome bc1 complex.  The key feature of this 
model is the presence of two separate ubiquinol/ubiquinone binding sites; a ubiquinol 
oxidation site (QP) near the P (inter-membranes space) side of the mitochondrial inner 
membrane, and a ubiquinone reduction site (QN) near the N (matrix) side.  Due to a lack 
of information on the binding of ubiquinol at the putative QP site from the 3-D structures, 
the detailed bifurcation of ubiquinol oxidation, the key step in the Q-cycle mechanism is 
difficult to establish.  Several models of the bifurcated oxidation of ubiquinol at the QP 
site have been proposed (22-28). 
 It has been established that for every electron transferred through the bc1 complex 
two protons are translocated across the membrane.  This 2 H+/e- stoichiometry has been 
verified in a wide variety of species, in vitro, by studying bc1 complexes in phospholipid 
(PL) vesicles.  Proton-pumping by bc1 complex inlaid PL vesicles requires an intact 
membrane which prevents non-specific proton leakage.  Any compromise of membrane 
integrity results in loss of the proton electrochemical gradient, as is observed when an 
uncoupler like carbonyl cyanide m - chlorophenylhydrazone (CCCP) is added to either 
intact mitochondria or PL vesicles harboring electron transfer complexes.  The integrity 
of the membrane is maintained by its protein and lipid components.   
 Although the proton translocation pathway in the cytochrome bc1 complex is not 
fully understood, the involvement of the [2Fe-2S] cluster of ISP has been suggested.  
When bovine mitochondrial bc1 complex is illuminated with a projector light in the 
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 presence of hematoporphyrin under aerobic conditions, the complex becomes inactivated 
as the [2Fe-2S] cluster in the treated complex is destroyed (29).  When photo-inactivated 
bc1 complex is co-inlaid in PL vesicles with intact bovine bc1 complex, no proton 
ejection is detected during ubiquinol oxidation.  These findings suggest that a proton-
permeable channel is created in the photo-inactivated complex.  However, since the 
hematoporphyrin promoted photo-inactivation site in the bc1 complex is not specific, the 
formation of a proton-leaking channel in the photo-inactivated complex may result from 
the oxidation of key amino acid residues in the bc1 complex, rather than from destruction 
of the [2Fe-2S] cluster alone.  Therefore, in order to unambiguously establish the 
involvement of the [2Fe-2S] cluster in the proton transfer pathway, a bc1 complex either 
lacking the cluster, or possessing a damaged one, is necessary.  We think that such a bc1 
complex can be obtained by site-directed mutagenesis of histidine residues H131 and 
H152 of the ISP, that serve as ligands to the [2Fe-2S] cluster.  
 Herein, we report the generation and characterization of R. sphaeroides strains 
expressing cytochrome bc1 complexes with substitutions at one or both the histidine 
ligands of the [2Fe-2S] cluster.  The proton-pumping activities of the protein-PL vesicles 
containing intact bovine mitochondrial bc1 complex, or cytochrome c oxidase, and the 
mutant complex were determined, and compared to those of protein-PL vesicles 
containing intact mitochondrial bc1 complex or cytochrome c oxidase and wild-type 
bacterial bc1 complex.  Restoration of proton-pumping activity was explored by adding 
excess amounts of ISP head domain containing the [2Fe-2S] cluster to proton-leaking PL 
vesicles embedding mitochondrial bc1 complex and thermolysin digested bacterial bc1 
complex.   
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EXPERIMENTAL PROCEDURES 
Materials - Cytochrome c (horse heart, Type-III), carbonyl cyanide m-
chlorophenylhydrazone, and thermolysin were from Sigma.  Azolectin was obtained 
from Associate Concentrate and purified according to the method of Racker and Kagawa 
(30).  n-Dodecyl-β-D-Maltoside and n-Dodecyl-β-D-Glucoside were from Anatrace.  Ni-
NTA gel and Qiaprep Spin Miniprep kit were from Qiagen.  2, 3-Dimethoxy-5-methyl-6-
bromodecyl-1, 4-benzoquinol (Q0C10BrH2) was prepared in our laboratory as previously 
reported (11).  All other chemicals were of the highest purity commercially available.  
Generation of R. sphaeroides Strains Expressing the His6-tagged bc1 Complexes 
with Mutation at the Histidine Ligand of the [2Fe-2S] cluster of ISP - Mutations were 
constructed with the Quik ChangeTM site-directed-mutagenesis kit from Sratagene using 
a supercoiled double-stranded pGEM7Zf(+)-fbcFB as template, and a forward and 
reverse primer for PCR amplification.  The pGEM7Zf(+)-fbcFB plasmid (31) was 
constructed by ligating the EcoRI - XbaI fragment from pSELNB3503 into the EcoRI 
and XbaI sites of the pGEM7Zf(+) plasmid.  The primers used were;    
H131C (F): GCGTCTGCACCTGCCTCGGCTGCGTGC 
H131C(R): GCACGCAGCCGAGGCAGGTGCAGACGC  
H152C (F):  GTTCTGCCCCTGCTGCGGATCGCACTACG 
H152C (R): CGTAGTGCGATCCGCAGCAGGGGCAGAAC 
F and R in parenthesis denote forward and reverse primers respectively.  The EcoRI -
XbaI fragment from the pGEM7Zf(+)-fbcFmB plasmid was ligated into the pRKD418-
fbcFBKmCHQ plasmid to generate the pRKD418-fbcFmBCHQ plasmid.  A plate-mating 
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 procedure was used to mobilize the pRKD418-fbcFmBCHQ plasmid from Escherichia 
coli S17-1 cells into R. sphaeroides BC-17 cells, as previously described (32).  The 
presence of the engineered mutations was confirmed by DNA sequencing, before and 
after semi-aerobic growth of the cells.  The expression plasmid, pRKDfbcFmBCHQ, was 
purified from an aliquot of semi-aerobically grown culture using the Qiagen Plasmid 
Mini Prep kit.  Since R. sphaeroides cells contain four types of endogenous plasmids, the 
isolated plasmids lack the purity and concentration needed for direct sequencing.  
Therefore, a 2-kilobase pair DNA segment containing the mutation sequence was 
amplified from the isolated plasmids by polymerase chain reaction (PCR), and 
sequenced.  DNA sequencing and oligonucleotide syntheses were carried out at the 
Recombinant DNA / Protein Core Facility at Oklahoma State University. 
Growth of bacteria - Escherichia coli cells were grown at 37oC in LB medium.  
For semi-aerobic growth of the plasmid-bearing R. sphaeroides BC-17 cells, an enriched 
Sistrom’s medium (33) supplemented with twenty amino acids, and extra-rich vitamins 
were used.  Cells harboring the mutated fbc genes on the pRKDfbcFmBCHQ plasmid 
were grown semi-aerobically for only one or two serial passages, in order to minimize 
any pressure for reversion.  The semi-aerobic cultures were grown in 800 ml of enriched 
Sistrom’s medium in 2 L Bellco flasks with vigorous shaking (150 rpm) for about 26 
hours at 30 oC in the dark.  The inoculation volumes used for semi-aerobic growth were 
at least 5 % of the total volume.  Antibiotics were added to the following concentrations: 
ampicillin (125 µg/ml), kanamycin sulfate (30 µg/ml for E. coli and 20 µg/ml for R. 
sphaeroides), tetracycline (10 µg/ml for E. coli and 1 µg/ml for R. sphaeroides), and 
trimethoprim (100 µg/ml for E. coli and 30 µg/ml for R. sphaeroides).  
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 Enzyme Preparations and Activity Assay - Chromatophores and intra-cytoplasmic 
membranes (ICM’s) were prepared as described previously (10), and stored at –80 oC in 
the presence of 20 % glycerol.  The His6-tagged cytochrome bc1 complexes were purified 
from frozen ICM’s or chromatophores by the method of Tian et al. (10).  Purified 
cytochrome bc1 complexes were stored at –80 ˚C in the presence of 10% glycerol.  To 
assay ubiquinol-cytochrome c reductase activity, membrane preparations or purified 
cytochrome bc1 complexes were diluted with 50 mM Tris-Cl, pH 8.0 containing 200 mM 
NaCl and 0.01% n-dodecyl-β-D-maltopyranoside (DM) to a final cytochrome b 
concentration of 1 µM.  5 µl of the diluted samples were added to 1 ml of assay mixture 
containing 100 mM of sodium phosphate buffer (pH 7.4), 0.3 mM EDTA, 50 µM 
ferricytochrome c, and 25 µM Q0C10BrH2.  Activities were determined by measuring the 
reduction of cytochrome c, by following the increase in the absorbance at 550 nm, in a 
Shimadzu UV-2101 PC spectrophotometer at 23 ˚C using a millimolar extinction 
coefficient of 18.5 mM-1cm-1 for calculations.  The non-enzymatic oxidation of 
Q0C10BrH2, determined under similar conditions in the absence of the enzyme, was 
subtracted during calculations for the specific activity.  Potassium cyanide was added to 
a final concentration of 30 µM in the assay mixture, to inhibit cytochrome c oxidase 
(CcO) when determining the bc1 activity in ICM’s or chromatophores. 
Preparation of Electron-Transfer Complex Inlaid PL Vesicles - Protein-PL 
vesicles were prepared by the cholate dialysis method of Racker and Kagawa (30).  
Bovine heart ubiquinol-cytochrome c reductase or CcO, either singly, or in combination 
with R. sphaeroides wild-type or mutant bc1 complex, was mixed with 1 ml of asolectin 
micellar solution to give an asolectin (mg) / protein (mg) ratio of 40.  The asolectin 
 34
 micellar solution was prepared by sonicating 200 mg of acetone-washed asolectin in 4 ml 
of 50 mM sodium phosphate buffer, pH 7.4, containing 2 % sodium cholate and 100 mM 
KCl (for use in preparation of bc1 complex-PL vesicles), and in 4 ml of 100 mM Hepes-
KOH, pH 7.3, containing 10 mM KCl and 2 % sodium cholate (for use in preparation of 
CcO-PL vesicles), in an ice-water bath.  Sonication was performed in an anaerobic 
environment by continually passing argon into the vessel.   
The bc1 complex-PL mixtures were incubated at 0˚C for 30 minutes before 
overnight dialysis at 4 °C against 100 volumes of 50 mM sodium phosphate buffer, pH 
7.4 containing 100 mM KCl with three changes of buffer.  The mixture was then 
dialyzed against 100 volumes of 150 mM KCl for 3 to 4 hours.  The CcO-PL mixture 
was dialyzed against 100 mM Hepes-KOH, pH 7.3, containing 10 mM KCl for 4 hours 
followed by 10 mM Hepes-KOH, pH 7.3, containing 50 mM KCl and 50 mM sucrose 
with one change of buffer for 12 hours each.  Subsequently, the vesicles were dialyzed 
against two changes of 50 µM Hepes-KOH buffer, pH 7.3, containing 55 mM KCl and 
55 mM sucrose, for 12 hours and 4 hours (34).  
Determination of Proton Translocating Activity of bc1 complex-PL Vesicles - 
Proton translocation coupled to electron flow through the bc1 complex-PL vesicles was 
measured at room temperature using an Accumet Model 10 pH meter and a Model 13-
620-96 combination pH electrode.  Twenty-five nmoles of Q0C10BrH2 was added to 1.6 
ml reaction mixture containing 150 mM KCl, 4 µM ferricytochrome c, 1 µM 
valinomycin, and an appropriate amount of bc1-PL vesicles (30 to 50 µl).  Electron flow 
was initiated by the addition of 5 nmoles of ferricyanide, which oxidizes the cytochrome 
c, and thus provides an electron acceptor for the complex.  Electron flow under 
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 conditions where no transmembrane ∆pH formed was measured in an identical manner 
except that the protonophore, CCCP, was present at a concentration of 2 µM to make the 
vesicles permeable to protons.  Proton-pumping (H+/e-) was calculated as the ratio of the 
decrease in pH upon ferricyanide addition to bc1-PL vesicles before and after treatment 
with CCCP.   
Determination of Proton Pumping Activity of CcO-PL vesicles - Proton-pumping 
experiments involving CcO-PL vesicles were conducted at 23oC in a stopped-flow 
spectrophotometer from Applied Photophysics, SX.18MV.  Reaction vessel A contains 2 
µM CcO-PL vesicles, 110 µM phenol red, 2 µM valinomycin in 50 µM Hepes-KOH, pH 
7.3, and 55 mM KCl.  Reaction vessel B contains 30 µM horse heart ferrocytochrome c 
in the same buffer (34).  Electron flow was initiated by mixing equal volumes of the 
reaction components in vessels A and B.  Proton pumping was measured by monitoring 
the absorbance changes of phenol red at 556.6 nm.  At this wavelength, the absorption 
change due to cytochrome c is minimal as it is the isobestic point for cytochrome c.  
Since the pH of the components of vessels A and B were the same, no non-specific 
absorbance changes should be observed.  
Preparation of the head domain of ISP (ISF) from R. sphaeroides bc1 complex – 
The method used for the preparation of ISF from mitochondrial bc1 complex (35) was 
adapted to prepare the ISF from wild-type R. sphaeroides bc1 complex.  Two µM wild-
type R. sphaeroides bc1 complex was suspended in 50 mM Tris-Cl, pH 8, containing 5 
mM CaCl2 and 100 mM NaCl.  0.2 µM thermolysin was added, and the reaction mixture 
was incubated at room temperature for three hours.  Thermolysin digestion of the bc1 
complex was stopped by the addition of 10 mM EDTA.  The EDTA containing reaction 
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 mixture was dialyzed overnight against 10 mM NaCl, 10 mM EDTA, and 10 mM 
phosphate buffer pH 7.2 with one change of buffer.  The dialyzed sample was 
centrifuged at 150,000 x g for 3 hours.  The precipitate was discarded and the 
supernatant was applied to a calcium phosphate: cellulose column (36) equilibrated with 
150 mM NaCl, and 10 mM phosphate buffer, pH 7.2.  Calcium phosphate was prepared 
according to Jenner (37) and mixed at a 3:1 ratio with cellulose powder, prior to use in 
column chromatography, for enhancement of the flow rate.  The ISF did not bind to the 
column under these conditions and was recovered in the column effluent, which was then 
concentrated to about 0.5 mg/ml using Centriprep YM-3 from Amicon.  The 
concentrated ISF was applied to a Mono-Q column (from Amersham Pharmacia) 
equilibrated with 20 mM MOPS, pH 6.2, containing 20 mM NaCl.  Thermolysin was not 
absorbed by the column and therefore removed in the effluent.  The ISF-absorbed 
column was subjected to a stepwise NaCl gradient wash; and ISF was eluted at 100 mM 
NaCl.  The complete removal of thermolysin in the ISF containing fractions was assured 
by the absence of protease activity, assayed using casein as substrate. 
Other Biochemical and Biophysical Techniques - Protein concentration was 
determined by the method of Lowry et al. (38).  Cytochrome b (39) and cytochrome c1 
(40) concentrations were determined according to published methods.  SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) was performed according to Laemelli 
(41) using a Bio-Rad Mini-protean dual slab vertical cell.  The polypeptides separated in 
the SDS-PAGE gel were transferred electrophoretically to a 22 micron nitrocellulose 
membrane for Western blotting.  Polyclonal antibodies generated against ISP of the R. 
sphaeroides bc1 complex were used as the primary antibody to detect their respective 
 37
 antigens (10).  Protein A conjugated to horseradish peroxidase, from Biorad, was used as 
the second antibody.  The [2Fe-2S] cluster of ISP was determined by EPR, using a 
Bruker EMX spectrometer equipped with an Air Products flow cryostat, and by circular 
dichroism (42, 43), using a Jasco J-715 spectropolarimeter.  Instrument settings are 
detailed in the legends of the relevant figures.  
 
RESULTS AND DISCUSSION 
Characterizations of Mutants Carrying Mutations at the Histidine Ligands of 
[2Fe-2S] cluster in ISP -  Four R. sphaeroides mutants expressing His6-tagged bc1 
complexes with mutations at the histidine ligands of [2Fe-2S] cluster were generated for 
this study.  They are: three single mutants, H131N, H152N, and H131C and a double 
mutant, H131C-H151C.  For mutants to be useful for this study, the resulting mutant 
complexes must lack the [2Fe-2S] cluster but have protein and redox components similar 
to those in the wild-type complex.  
 When mid-log phase, aerobically dark grown wild-type and mutant cells were 
inoculated into enriched Sistrom’s medium and subjected to anaerobic photosynthetic 
growth conditions, all four mutants did not grow.  However, these mutants grew 
aerobically and semi-aerobically at rates comparable with that of wild-type cells.  These 
results indicate that the four mutants have a defective cytochrome bc1 complex, since this 
complex is absolutely required for photosynthetic growth of this bacterium (See Fig. 7).  
When ICM’s were prepared from semi-aerobically grown mutant cells and assayed for 
ubiquinol-cytochrome c reductase activity, none was detected in the four mutant 
membranes.  Absorption spectral analysis reveals that the content and absorption spectral 
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 properties of cytochrome b and cytochromes (c1+c2) in all these mutant membranes are 
similar to those in the complement chromatophores or ICM (See Table 3), indicating that 
the mutation does not affect the assembly of cytochrome b and c1 into the membrane.  
EPR analysis reveals that these four mutant membranes contain no [2Fe-2S] cluster of 
ISP, indicating that the mutation results in an inability of the [2Fe-2S] cluster to be 
ligated to apo-ISP, thereby leading to loss of bc1 activity.  Western blot analysis using 
antibodies against R. sphaeroides ISP shows that H131N, H152N, H131C, and H131C-
H151C mutant ICM’s have 9, 58, 64, and 98 % of the apo-ISP in the wild-type 
chromatophores respectively as determined by densitometer scan analysis (See Table 3).  
Apparently, the stability of apo-ISP is affected by the type of amino acid substituting for 
the histidine ligand, and whether the alteration is at H131 or H152.  The finding, that the 
H152N mutant ICM has more apo-ISP than does the H131N mutant membrane, is similar 
to observations in yeast mutants of H161R and H181R (44).  However, it differs from 
reports on mutation at histidine ligands of [2Fe-2S] cluster in R. capsulatus, in which less 
than 3 % of the apo-ISP is found in the mutant membranes (45).   
When the His6-tagged bc1 complexes were purified from the ICM of the four 
mutants, none of them had bc1 activity or the [2Fe-2S] cluster of ISP.  As shown in Fig. 
8, EPR signals at g = 2.03, 1.90 and 1.80, characteristics of the [2Fe-2S] cluster of ISP, 
are observed only in the purified wild-type complex.  Similarly, a negative CD peak 
around 500 nm, a characteristic of the [2Fe-2S] cluster of ISP, is observed only in the 
purified wild-type complex.  Therefore, EPR and CD analysis of the mutant complexes 
clearly indicates the loss of the [2Fe-2S] cluster.  
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Cyt b/(cyt c1+c2) Cyt b/(cyt c1) 
 Membrane 
Cytochrome bc1 complex 
  Purified complex Strains 
ISP contenta
Table 3 
Characterizations of mutants lacking the Rieske [2Fe-2S] cluster 
ISP contenta
Complement 1.20 1.00 1.31 1.00 
H131N 1.16 0.09 0.46 0.00 
H152N 1.20 0.58 0.50 0.40 
H131C 1.21 0.64 0.80 0.55 
H131C/H152C 1.20 0.98 1.10 0.82 
 
a ISP content was quantified using a Biorad GS-700 Imaging Densitometer.  It is 
expressed as a fraction of the amount present in the complement wild type. 
complex.   
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Figure 8.  EPR and CD characterization of the [2Fe-2S] cluster in the cytochrome 
bc1 of complement and mutant complexes.  EPR spectra of purified bc1 complexes of 
wild-type (A), H131C (B) and H131C-H152C (C) are shown in the left hand panel.  The 
bc1 complexes were incubated with 1.5 mM ascorbate on ice for 30 minutes and frozen in 
liquid nitrogen.  EPR spectra were recorded at 8 K with the following instrument 
settings: microwave frequency, 9.3 GHz; modulation frequency, 100 kHz; modulation 
amplitude, 6.3 G; time constant, 655.4 ms; and sweep time, 167.8 s.  CD spectra for 
purified bc1 complexes of complement (A), H131C (B) and H131C-H152C (C) are 
shown in the right hand panel.  The bc1 complexes were diluted to a final concentration 
of 5.5 µM in 50 mM Tris-HCl, pH 7.5, 100 mM NaCl and 0.01 % DM.  The 
experimental conditions were: band width, 1.0 nm; step resolution, 1.0 nm; cell length, 1 
cm; and scan speed, 50 nm/min.  Each trace represents an average of four data sets.  
Reduced (solid lines), and oxidized (dotted lines) bc1 complexes were prepared by the 
addition of ascorbate and ferricyanide, respectively.   
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The b/c1 ratios in the complement and mutants H131N, H152N, H131C, H131C-
H152C, determined by absorption spectra (see Fig. 9 and Table 3), are 1.31, 0.46, 0.50, 
0.80 and 1.10 respectively, indicating that the binding affinity between cytochrome b and 
cytochrome c1 is affected by the nature and position of the substituting amino acids.  A 
decrease in the b/c1 ratio indicates a decrease in binding affinity between the two 
cytochromes.  Since the expressed R. sphaeroides bc1 complex is His6 tagged at the C-
terminus of cytochrome c1, all cytochrome c1 from the dodecylmaltoside solubilized 
membrane, regardless of whether or not it is associated with cytochrome b, will be 
absorbed to the Ni-NTA column used in the one-step purification of the complex.  The 
cytochrome b which is not tightly associated with cytochrome c1 will appear in the 
effluent.  Consequently the eluted complex would have a lower b/c1 ratio as compared to 
the wild-type complex.  The possibility that the lower cytochrome b/c1 ratio observed in 
the mutant complexes results from a difference in the effectiveness of DM solubilization 
of the mutant complex from the membrane has been ruled out.  DM solubilization of the 
bc1 complexes from the mutant membranes was comparable to that of the complement 
(wild-type) chromatophores.  It should be mentioned that EPR signals for both bL (g 
=3.76) and bH (g =3.49) are detected in the H131N mutant complex, indicating that this 
mutation does not affect the heme environments of cytochrome b, despite the loss of 
more than 65 % of the cytochrome b from the DM-solubilized membrane during 
purification by an Ni-NTA column.  The EPR signals for bL and bH are observed in all of 
the [2Fe-2S] cluster lacking mutants (Fig. 10). 
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Figure 9.  Absorption spectra of purified bc1 complexes of the complement wild-
type, and mutants lacking the [2Fe-2S] cluster.   Purified protein complexes from wild 
type (A), H131C-H152C (B), H131C (C), H131N (D), and H152N (E) were diluted in 50 
mM Tris-Cl, pH 8, containing 200 mM NaCl and 0.01 % DM.  A few granules of 
dithionite were added to reduce cytochrome b.  Each optical spectrum is a calculated 
difference spectrum of the dithionite-reduced minus ferricyanide-oxidized cytochromes 
(Absmax = 551 nm for cytochrome c1, and Absmax = 560 nm for cytochrome b). 
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Table 4 
Proton-pumping ratios (H+/e-) for PL vesicles harboring mitochondrial bc1 and bacterial bc1 
complexes. 
 
 
 
 
 
mitochondrial bc1 (m-bc1) 1.9 
wild type R. sphaeroides bc1 1.5 
m-bc1 + wild type 1.7 
m-bc1 + H131C-H152C 1.0 
m-bc1 + (thermolysin digested bacterial bc1) 1.0 
m-bc1 + (thermolysin digested bacterial bc1 + ISF)b 1.3 
  
(H+/e-)aVesicle Type 
 
 
a H+/e- is defined under ‘Experimental Procedures.’  For the experimental conditions, see legend to 
Fig. 14. 
b ISF, Rieske Iron-Sulfur Fragment  
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 Fig. 11 shows Western blot analysis of ISP in the complement and mutant complexes.  
Although the purified H131N mutant complex contains no detectable apo-ISP or subunit 
IV,  purified mutant complexes of H152N, H131C, and H131C-H152C have 40, 55, and 
82 % respectively, of the amount of apo-ISP or subunit IV found in the complement 
complex.  When the latter three mutant complexes are subjected to SDS-PAGE analysis, 
four major protein bands corresponding to cytochrome b, cytochrome c1, ISP and Subunit 
IV are observed, as in the complement wild-type complex (see Fig. 11).  Thus a 
significant amount of ISP, 40 - 82 %, is still present in the [2Fe-2S] cluster lacking 
mutant complexes but not in H131N.  It has been reported that a yeast mutant strain 
whose [2Fe-2S] cluster is lacking has about 83 % of the ISP, relative to cytochrome c1, in 
the purified complex, when compared to its wild-type counterpart (46).  
Clearly, the assembly of the bc1 complex depends critically on the structural 
integrity of the head domain of ISP, particularly at the tip of ISP where interaction 
between ISP and cyt. b takes place.  A unique feature of the ISP head domain structure is 
the tip area where the [2Fe-2S] cluster is located; the surface topology of the tip is 
strikingly smooth with only main chain atoms facing the solvent environment.  
Substitutions of H131C and H152C by molecular modeling using the bovine ISP 
structure as a template demonstrated (Fig. 12) the formation of two possible disulfide 
bonds, between C141 and C161 for one pair, and between C139 and C158 for the other, 
in the absence of the [2Fe-2S] cluster.  Together with the disulfide pair in the native 
structure between C144 and C160, the three pairs of disulfide-bridge in the mutant would 
stabilize the structure of ISP at the tip region and perhaps more importantly maintain the 
smooth surface topology of the wild-type ISP, whereas any of the other single amino acid  
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Figure 10.  EPR spectra of cytochromes b in the cytochrome bc1 complexes of 
complement wild type and the [2Fe-2S] cluster lacking mutants.  Purified 
cytochrome bc1 complexes from wild type (A), H131N (B), H152N (C), H131C (D), and 
H131C-H152C (E) was diluted in 50 mM Tris-Cl, pH 8, containing 200 mM NaCl and 
0.01 % DM.  Instrument settings were the same as in Fig. 8, except that the microwave 
power used was 108.1 mW, and the modulation amplitude was 20 G. 
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Figure 11.  SDS-PAGE and Western Blot analysis of purified cytochrome bc1 
complexes of complement wild-type and [2Fe-2S] cluster lacking mutants.  Aliquots 
of wild-type, and the mutant purified complexes were incubated with 1 % SDS and 0.4 % 
β -mercaptoethanol at room temperature for 30 minutes.  Digested samples containing 
100 pmoles of cytochrome b were subjected to electrophoresis (panel A).  Lane 1, pre-
stained molecular weight standard; Lane 2, wild-type; Lane 3, H131N; Lane 4, H152N; 
Lane 5, H131C; Lane 6, H131C-H152C.  The proteins in the gel were transferred 
electrophoretically to a 22 micron nitrocellulose membrane, and reacted with antibodies 
against R. sphaeroides ISP.  The horseradish peroxidase system was used to develop the 
membrane (panel B).  Lane designations are the same as above. 
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Figure 12.   Ribbon representation for the structural model of the mutant lacking 
the Rieske [2Fe-2S] cluster.  The model is represented with the bovine iron sulfur 
protein (ISP) structure, and the double mutation in ISP of R. sphaeroides bc1 corresponds 
to H141C / H161C of the bovine sequence.  The tip area of the ISP is highlighted with a 
red circle.  The three pairs of disulfide bonds are depicted with the ball-and-stick model 
with carbon atoms in black and sulfur atom in yellow, and are as labeled. 
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 substitutions would inevitably destroy to a different extent this important feature.  The 
H131N and H152N mutations are particularly unfavorable due to exposed large side 
chains. 
 Among the four [2Fe-2S] cluster lacking mutant bc1 complexes, H131C and 
H131C-152C are suitable for probing the function of the [2Fe-2S] cluster in proton 
translocation, because they differ from the wild-type complex only in the lack of the 
[2Fe-2S] cluster.  The content of subunits and spectral properties of cytochromes b & c1 
in these two mutant complexes are similar to those in the complement complex.  
Moreover, the amount of ISP in the purified complexes is over 50 % compared to the 
complement (wild type) complex.  Therefore, any changes in proton translocation 
activity detected in these two mutant complexes can be unambiguously attributed to the 
lack of [2Fe-2S] cluster.   
Proton Translocation Activity of Intact Mitochondrial bc1 Complex Co-inlaid in 
PL Vesicles with Wild-Type and H131C / H152C Mutant of R. sphaeroides complexes - 
An important property of the cytochrome bc1 complex is the ability to pump protons 
across the membrane during electron flow from ubiquinol to cytochrome c.  This 
property has been well demonstrated in PL vesicles embedding purified mitochondrial 
bc1 complex (47-50).  A simplified, cartoon representation of proton translocation 
coupled to electron transfer by a cytochrome bc1 complex embedded in a PL vesicle is 
shown in Fig. 13.  Fig. 14-A shows a typical proton translocation activity assay for PL 
vesicles embedding bovine bc1 complex.  After pH equilibrium is reached for a mixture 
containing Q0C10BrH2, valinomycin, ferricytochrome c, and bovine bc1 complex-PL 
vesicles, an aliquot of ferricyanide solution (addition 1) is added to initiate electron  
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Figure 13.  Cartoon depiction and scheme of proton translocation in phospholipids 
(PL) vesicles embedded with active bc1 complexes.  Protein embedded PL vesicles 
were generated as described in “Experimental Procedures”.  The reaction was started by 
adding ferricyanide, which oxidizes cytochrome c triggering electron flow from QH2 to 
cytochrome c via the PL-embedded bc1 complex.  Scalar protons released by direct 
oxidation of QH2 (blue), and vectorially translocated protons (red) are shown.  Proton 
pumping, from inside the vesicle to the outside, was measured as a function of the 
decrease in pH of the reaction mixture, i.e. outside the PL vesicles using an Accumet pH 
electrode.  Valinomycin (red cylinder), a potassium specific ionophore, facilitating the 
movement of potassium ions through lipid membranes down an electrochemical gradient, 
was used to negate the contribution of electric potential to the proton motive force.  The 
buffer trapped inside the vesicle was 50 mM Na+/ K+ phosphate, pH 7.4, containing 100 
mM KCl.  Only one bc1 dimer is shown embedded in the PL vesicle for simplicity, as the 
total number of bc1 complexes embedded in the vesicles was not determined.           
K+
H+ ferricyanide
cyt. c 
Q
 2H+
QH2
e-
ferrocyanide
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  flow from Q0C10BrH2 to cytochrome c.  Ferricyanide oxidizes the cytochrome c in the 
reaction mixture triggering electron flow from ubiquinol to the bc1 complex that is 
coupled to proton translocation and acidification of the reaction mixture (Fig 13).  Two 
types of protons, scalar and vectorial, contribute towards the generated electrochemical 
potential.  ‘Scalar protons’ arise as a result of the direct oxidation of ubiquinol by the bc1 
complex while ‘vectorial protons’ are translocated from the inside of the PL vesicle to 
the outside (Fig. 13).  In the presence of valinomycin, the electrochemical potential 
gradient generated consists of only the chemical potential.  Valinomycin, a potassium 
specific ionophore, facilitates the movement of potassium ions through lipid membranes 
down an electrochemical gradient preventing the build-up of electric potential across the 
PL vesicle.  Failure to dississipate the electric potential across the PL vesicle prevents 
further electron transfer and proton translocation resulting in inhibition of the reaction.  
After pH equilibrium is attained, a protonophore, CCCP, is added (Fig. 14, addition 2) to 
render the liposome membrane freely permeable to protons, and then a second aliquot of 
ferricyanide is added (addition 3).  In the presence of CCCP, the integrity of the PL 
vesicle is compromised as proton flow is readily permissible.  Compartmentalization no 
longer exists, resulting in abolishment of proton pumping.  The ratio of the pH changes 
produced by the addition of equal amounts of ferricyanide, before (x) and after (y) the 
addition of CCCP, is taken as a measure of the H+/ e- ratio for proton translocation 
activity of the bc1 complex.  The protons released after CCCP addition are the ‘scalar’ 
protons only, as no contribution from the accumulation of ‘vectorially’ translocated 
protons is possible.  Ratios (i.e. x/y) between 1.6 and 2.0 are routinely obtained with 
liposomes containing the bovine mitochondrial bc1 complex (48). 
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Figure 14.  The proton-pumping of cytochrome bc1 complexes embedded PL 
vesicles.  Measurement of the proton-pumping activity of PL vesicles embedded with 
mitochondria bc1 complex only (A), and mitochondrial bc1 complex co-embedded with 
the [2Fe-2S] cluster lacking mutant complex, H131C-H152C (B) using ubiquinol as the 
substrate.  Arrows indicate the points of addition of 6 nmoles of ferricyanide (1), 3 uM 
CCCP (2), 6 nmoles of ferricyanide (3), and 5 nmoles HCl (4).  Note: proton-pumping 
ratio (H+/e-) = x / y. 
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 When wild-type R. sphaeroides bc1-PL vesicles, prepared in the same manner as that of 
mitochondrial-PL vesicles, are subjected to proton pumping activity measurement, a H+/ 
e- ratio of 1.5 - 1.6 is obtained (see Table 4).  The proton pumping ratio for vesicles 
embedding bacterial bc1 complex is lower than that obtained for PL vesicles embedding 
mitochondrial bc1 complex probably because the vesicles are not as tightly sealed.  As 
expected, no proton translocation activity is found in PL vesicles embedding the H131C-
H152C mutant complex, since it lacks ubiquinol-cytochrome c reductase activity.  When 
the wild-type bacterial bc1 complex is co-embedded in PL vesicles with the intact 
mitochondrial bc1 complex, a H+/e- ratio of 1.7 is obtained.  However, when the H131C-
H152C mutant complex is co-inlaid in PL vesicles with the mitochondrial bc1 complex, 
no proton-pumping is observed; i.e., H+/ e- ratio equals 1.0 (see Fig. 14B and Table 4).  
This indicates that a proton-leaking channel is present in the H131C-H152C mutant 
complex whose [2Fe-2S] cluster is lacking.  Incorporation of the mutant complex into 
actively proton-pumping liposomes has a similar effect as the addition of CCCP; i.e. they 
both allow the free flow of protons across the PL vesicle, preventing the generation of a 
gradient.  It should be noted that the proton translocation activity (H+/e-) in protein-PL 
vesicles containing intact mitochondrial bc1 and the H131C-H152C mutant complexes 
decreases as the relative amount of mutant complex in the vesicle increases.  A complete 
loss of proton-pumping activity is observed when the mutant complex concentration is 
three-fold that of the mitochondrial bc1 complex.  An excess of the [2Fe-2S] cluster 
lacking mutant complex is necessary to ensure that every PL vesicle harbors at least one 
mutant complex in addition to a mitochondrial bc1 complex.  
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 Proton Translocation Activity of Intact Mitochondrial Cytochrome c Oxidase Co-inlaid 
in PL Vesicles with Wild-type and Mutant Bacterial Complexes – The ability of the 
H131C-H152C mutant bc1 complexes to form proton-leaking channels is further 
demonstrated by co-embedding with bovine mitochondrial CcO.  Like the cytochrome 
bc1 complex, electron transfer through CcO is coupled to proton translocation across the 
membrane in which the complex is housed.  When purified bovine CcO is embedded in 
PL vesicles, the accumulation of vectorially translocated protons is detected during the 
oxidation of reduced cytochrome c as indicated by acidification of the external medium 
(Fig. 15).  However, when CcO is co-inlaid in PL vesicles with a five-fold or higher 
molar excess of the H131C-H152C mutant bc1 complex, the vesicles produce an instant  
alkalization phase during the oxidation of reduced cytochrome c.  The pattern of pH 
increase is similar to that observed in CCCP treated PL vesicles embedding CcO, thereby 
further indicating the presence of a proton leaking channel in the bc1 complex lacking the 
[2Fe-2S] cluster.  It should be noted that the proton translocation activity of CcO remains 
unchanged when co-inlaid in PL vesicles with a five-fold molar excess of wild-type bc1 
complex. 
 
Restoration of Proton Translocation Activity to Protein-PL Vesicles Containing Intact 
Mitochondrial bc1 and the Thermolysin-digested Bacterial Complex with the Head 
Domain of ISP – Since the cytochrome bc1 complex lacking the [2Fe-2S] cluster has a 
proton-leaking channel, the cluster may function as a proton-exiting gate regulating the 
controlled, vectorial extrusion of protons across the bc1 complex.  If removal of the [2Fe-
2S] cluster of ISP makes the bc1 complex proton permeable, a bc1 complex with the ISP 
head domain removed should be similar, since the [2Fe-2S] cluster is located in the head  
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Figure 15.  Determination of proton translocation of PL vesicles embedded with 
ytochrome c oxidase (CcO) and bacterial bc1 complex using stopped-flow 
spectrophotometer.  Reaction conditions were as described in Materials and Methods.  
H changes were monitored by following the change in absorbance of phenol red at the 
isobestic point of horse heart cytochrome c, 556.6 nm.  Reaction of 15 µM reduced 
ytochrome c with vesicles embedded with 0.75 µΜ bovine mitochondrial CcO only (A), 
cO and complement  R. sphaeroides bc1 complex (B), CCCP treated vesicles embedded 
ith CcO (C), and vesicles embedded with CcO and [2Fe-2S] cluster lacking mutant bc1 
plex, H131C-H152C (D). 
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  domain of ISP.  To confirm this prediction, a bacterial bc1 complex lacking the ISP head 
domain was prepared by thermolysin digestion and co-inlaid into PL-vesicles with intact 
mitochondrial bc1 complex.  The proton pumping activity of the resulting protein-PL 
vesicles was measured.  No proton-pumping is observed in protein-PL vesicles 
containing thermolysin-digested bacterial bc1 complex and mitochondrial bc1 complex at 
an 8:1 molar ratio.  The requirement of a large excess of thermolysin digested complex to 
completely abolish proton transfer activity may be due to incomplete removal of the head 
domain of ISP by thermolysin.  To examine this possibility, the digested complex, which 
has no ubiquinol-cytochrome c reductase activity, was subjected to SDS-PAGE and 
Western Blot analysis.  About 30 % of the ISP in the complex is resistant to thermolysin 
digestion (see Fig. 16).  Similar observations were made with R. capsulatus, where 
incubation of the bc1 complex with thermolysin for prolonged periods, with fresh 
additions of protease at 4 hr intervals does not yield complete digestion (51).   
Addition of excess purified ISF to proton-leaking PL vesicles co-embedding 
mitochondrial bc1 and thermolysin digested bacterial bc1 complex partially restores the 
proton-pumping capability with H+/e- ratios ranging from 1.35 to 1.40.  Probably the 
purified ISF docks at the vacant position once occupied by the cleaved head domain of 
ISP of the bacterial complex.  Reintroduction of the [2Fe-2S] cluster containing head 
domain seals the proton channel across the bc1 complex, preventing the uncontrolled and 
unimpeded proton flow across the protein-PL vesicles.  As expected, the addition of 
excess ISF to PL vesicles embedding mitochondrial bc1 complex, and the mutant 
complex, H131C-H152C, does not restore the proton-pumping activity because the 
mutant complex lacks only the [2Fe-2S] cluster, not the entire ISF, providing no room 
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Figure 16.  Western blot analysis of thermolysin-mediated proteolysis of purified R. 
sphaeroides bc  complex.  The R. sphaeroides bc  complex was treated with thermolysin 
0 
pmoles of cytochrome b were loaded into each well and subjected to SDS-PAGE.  The 
lose 
membrane and reacted with antibodies against R. sphaeroides ISP.  The horseradish 
ar 
weight standard; Lane 2, undigested wild-type R. sphaeroides bc  complex; Lane 3, 
des 
bc  complex. 
1 1
and incubated at room temperature as detailed in Methods.  Samples containing 10
proteins in the gel were transferred electrophoretically to a 22 micron nitrocellu
peroxidase system was used to develop the membrane.  Lane 1, pre-stained molecul
1
purified 18 kDa iron-sulfur fragment (ISF); Lane 4, thermolysin digested R. sphaeroi
1
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  for added ISF to dock.  Similarly, the addition of excess ISF to PL vesicles embedding 
m
ping 
 
intaining 
e 
amage needed to produce the proton leakage is removal of the [2Fe-2S] cluster.  It is 
at the matrix side (Fig. 17).  There is however a gap of roughly 17 Å in the mid-section 
of the TM domain where no ordered water molecules were found crystallographically. 
Proton transfer pathways involving internal water molecules that provide hydrogen bonds 
and facilitate proton diffusion have been identified in other membrane proteins like 
bacteriorhodopsin (52), and CcO (53).  Although the mechanisms for proton  
itochondrial bc1 complex and 2-band bc1 complex (a mutant bc1 complex containing 
only the cytochrome b and cytochrome c1 subunits) does not restore the proton-pum
capability of such vesicles.  The tail domain of ISP which is present in the thermolysin
digested complex and absent in the 2-subunit bc1 complex may play a role in ma
the conformation of the bc1 complex required for the docking of ISF.  
The Existence of Proton Pathway in the Cytochrome bc1 Complex - The 
observation of proton leakage in the bc1 complex with damaged ISP suggests a passage 
in the complex, channeling proton back-flow from the periplasmic to cytoplasmic sid
(from the inter-membrane space to matrix in mitochondria).  It is unlikely, although it 
can’t be ruled out, that such a channel exists in the trans-membrane (TM) region at the 
interfaces of different subunits, such as that between cyt. b and c1, because the only 
d
conceivable that the culprit lies in the cyt. b subunit as it contributes most to the TM 
region of the complex.  Based on the crystallographically refined structures (5, 8, 9), a 
solvent distribution around the subunit cyt. b was generated (Fig. 17), from which three 
principle solvent accessible regions in cyt. b could be defined where water molecules 
penetrate deep into the subunit: they are the Qi site, the Qo site, and the dimer interface 
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Figure 17.  Solvent molecule distribution for the bovine cytochrome b dimer.  
molecules are shown as red balls.  Heme moieties are given as the ball-and-stick mode
site, and in red rectangle is the hole at the dimer interface near the matrix.  The centra
 
 
 
The 
structure of cytochrome b dimer is shown as a Cα tracing, and associated water 
ls 
and are as labeled.  Highlighted in purple circle is the Qo site, in green circle is the Qi 
l 
cavity is also indicated. 
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 translocations are different for different proteins, the underlying principle for bringing 
 is 
 the  
There are two likely exit pathways for the proton leakage: one is via the Qi site 
nd the other is through a hole at the dimer interface (Fig. 17).  We have suggested 
arlier (9) that two residues in the Qi pocket may be involved in fetching protons from 
the matrix side; K227 and H201 undergo conformational changes that are coupled to 
ubiquinone reduction at the Qi site.  The same residues could serve as an exit gate in the 
case of proton leakage except that the gate is decoupled to ubiquinone reduction and is 
spontaneously open.  Alternatively, the proton could exit from the hole at the dimer 
water molecules or protons to the active sites is similar.  Several pathways for proton 
leakage are possible.  As indicated in Fig. 17, the proton entry for the leakage must be 
located at the Qo site where protons are ejected under normal circumstance.  All other 
venues near the intermembrane space side are sealed.  In the native cytochrome bc1 
complex, the [2Fe-2S] cluster undergoes redox state changes during the catalytic cycle.  
The ejection of protons must be controlled by the protonation and deprotonation of the 
histidine ligands of the [2Fe-2S] cluster.  The histidine ligands uptake a proton from the  
substrate, ubiquinol, upon reduction of the [2Fe-2S] cluster, and releases them to the 
inter-membrane space when oxidized by cytochrome c1 as was suggested recently (54).  
It is less clear how the second proton is pumped out, although Glu271 of cytochrome b
speculated to be the acceptor of the second proton from ubiquinol (54).  The absence of 
the histidine ligands, and thus the loss of the [2Fe-2S] cluster, explain well the loss of
proton-pumping capability in PL vesicles incorporating the mutant bc1 complexes.  The 
exact mechanism of how protons leak into the QP site in the absence of the [2Fe-2S] 
cluster remains to be seen. 
a
e
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 interface near the matrix side (Fig. 17).  The hole is just outside H201 and filled with 
ordered water molecules. 
The possibility of a direct proton translocation path going through the interior o
cyt. b is slim since the overall structure is rather rigid as analyzed by the binding of 
various inhibitors (8).  A likely pathway linking the entrance at the Q
f 
 gate 
 
o site to the exit
at the Qi site for spontaneous proton leakage is the large cavity formed between the two 
symmetry-related cyt. b subunits.  Although this cavity is fairly hydrophobic, one could
argue that the existence of the membrane potential (pH gradient) could overcome the 
thermodynamic barrier and facilitate proton movement from one side to the other. 
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  ABSTRACT 
tigmatellin, a QP site inhibitor, inhibits electron transfer from iron-sulfur protein (ISP) to 
cytochrome c1 in the bc1 complex.  Stigmatellin raises the midpoint potential of ISP from 
+290 mV to +540 mV.  The binding the fully oxidized complex, 
oxidized by catalytic amounts of cytochrome c oxidase and cytochrome c, causes ISP 
reduction.  The extent of ISP reduction is proportional to the amount of inhibitor used and 
reaches a maximum when the ratio of inhibit e complex reaches unity.  A g = 
stigmatellin is adde ependent on the 
mount of stigmatellin.  Addition of ferricyanide, a strong oxidant, to the oxidized 
complex also results i  oxidant 
oncentration dependent.  Oxygen radicals are generated when stigmatellin is added to 
e oxidized complex in the absence of the exogenous substrate, ubiquinol.  The amount 
f oxygen radical formed is proportional to the amount of stigmatellin.  Oxygen radicals 
re not generated when stigmatellin is added to a mutant bc1 complex lacking the Rieske 
on-sulfur cluster.  Slow reduction of cytochrome b is observed in bc1 complexes treated 
ith either stigmatellin or fericyanide.  Based on these results, it is proposed that ISP 
ecomes a strong oxidant upon stigmatellin binding, extracting electrons from an organic 
ompound, likely an amino acid residue.  This results in the reduction of ISP and 
eneration of organic radicals.  
S
 of stigmatellin to 
or to enzym
2.005 EPR peak, characteristic of an organic free radical, is also observed when 
d to the oxidized complex and its signal intensity is d
a
n the generation of a g = 2.005 EPR peak that is
c
th
o
a
ir
w
b
c
g
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 INTRODUCTION 
.  
) 
ron-
 called 
drial 
tion of the redox centers, the number of trans-membrane 
helices, quinone binding at the QN site, and inhibitor binding at both the QP and QN sites 
(2-4, 8, 9).  Moreover, these crystal structures suggest mobility of the extrinsic head 
The cytochrome (cyt) 1 bc1 complex, also known as ubiquinol-cytochrome c 
reductase or Complex III is the central segment of the energy conserving, electron 
transfer chain of mitochondria and many respiratory and photosynthetic bacteria (1)
This enzyme complex catalyzes electron transfer from ubiquinol to cyt c (c2 in bacteria
with concomitant translocation of protons across the membrane to generate a proton 
electrochemical gradient required for ATP synthesis by ATP synthase.  The cyt bc1 
complexes from all species contain three core subunits, cyt b, cyt c1 and Rieske I
Sulfur protein (ISP), that house two b type cyt (b566 and b562), one c-type cyt (c1) and a 
high potential Rieske [2Fe-2S] cluster.  Depending on the source, the cyt bc1 complex 
contains various numbers (0 to 8) of non-redox group containing subunits, also
supernumerary subunits.  
Recently, the 3-D crystal structures of mitochondrial bc1 complexes from bovine 
(2, 3), chicken (4) and yeast (5), which contain seven or eight supernumerary subunits in 
addition to the three core subunits, have been obtained.  The structure of the cyt b6f 
complex, a complex analogous to the cyt bc1 complex that provides an electronic 
connection between photosystems I and II, have also been established for the 
thermophilic cyanobacterium Mastigocladus laminosus (6), and for the algae 
Chlamydomonas reinhardtii (7).  The 3-D structural information for the mitochon
bc1 complex establishes the loca
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 domain of ISP during bc1 catalysis.  Strong evidence in support of this movement has 
been re
l is 
e, 
c 
e 
bitors, and assumptions are made to reflect a similar site for 
binding
, 
ough 
lu-272, 
he H-
1 
complexes.  The importance of phospholipids for binding of stigmatellin to the bc1 
ported (10-19). 
The proton-motive Q-cycle model (20, 21) has been favored for describing 
electron and proton translocation in the cyt bc1 complex.  The key feature of this mode
the presence of two separate ubiquinol/ubiquinone binding sites; a ubiquinol oxidation 
site (QP) near the P (inter-membranes space) side of the mitochondrial inner membran
and a ubiquinone reduction site (QN) near the N (matrix) side.  X-ray crystallographi
analyses revealed binding of ubiquinone at the QN site (5) of the cyt bc1 complex.  
Unfortunately, ubiquinone or ubiquinol binding at the QP site has not been observed in 
native crystal structures, thereby preventing establishment of the putative QP site.  
Therefore, discussions on the mechanisms of electron transfer are based primarily on th
positions occupied by inhi
 of the natural substrate, ubiquinol.  Detailed bifurcation of ubiquinol oxidation, 
the key step in the Q-cycle mechanism, is difficult to establish, although several models 
have been proposed (22-28).  Stigmatellin, a Pf inhibitor (29) of the cyt bc1 complex
binds to cyt b at a domain distal from heme bL.  It interacts with the Rieske ISP thr
the formation of an H-bond with His-161, and with cyt b by H-bonding with G
whose side chain undergoes a rotation of ~160o from its native position (9).  T
bonded configuration of quinone and stigmatellin in the bc1 complex were shown to be 
similar (27).  Hence, it is likely that the binding of stigmatellin resembles that of a quinol 
oxidation intermediate (5, 30).   
Herein, we report the affect of stigmatellin on the redox state of oxidized cyt bc
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 complex was established.  The generation of free radicals upon addition of stigmatellin
was explored by analysi
 
s of the g = 2.005 EPR signal.  Reduction of cyt b after addition 
of stigm  the 
. 
ate 
s 
smic 
 
 by the method of Tian et al. (10).  Purified cyt bc1 
comple
atellin to the oxidized complex was examined.  Production of superoxide by
bc1 complex, in the presence of stigmatellin, was determined in wild-type cyt bc1 
complex and compared to a mutant complex lacking the Rieske iron sulfur cluster (ISC)
 
EXPERIMENTAL PROCEDURES 
 
Materials - Cyt c (horse heart, Type-III), stigmatellin, MCLA, superoxide 
dismutase and thermolysin were from Sigma.  Azolectin was obtained from Associ
Concentrate and purified according to the method of Racker and Kagawa (31).  Octyl 
sepharose and DEAE-sepharose CL-6 were obtained from Pharmacia.  n-dodecyl-β-D-
maltopyranoside (DM) and n-dodecyl-β-D-glucopyranoside (DG) were from Anatrace.  
Ni-NTA gel and Qiaprep Spin Miniprep kit were from Qiagen.  2, 3-Dimethoxy-5-
methyl-6-bromodecyl-1, 4-benzoquinol (Q0C10BrH2) was prepared in our laboratory a
previously reported (11).  All other chemicals were of the highest purity commercially 
available. 
Enzyme Preparations and Activity Assay - Chromatophores and intra-cytopla
membranes (ICM’s) were prepared as described previously (10), and stored at –80 oC in
the presence of 20 % glycerol.  The His6-tagged cyt bc1 complexes were purified from 
frozen ICM’s or chromatophores
xes were stored at –80 ˚C in the presence of 10 % glycerol.  To assay ubiquinol-
cyt c reductase activity, membrane preparations or purified cyt bc1 complexes were 
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 diluted with 50 mM Tris-Cl, pH 8.0, containing 200 mM NaCl and 0.01 % DM to a fina
cyt b concentration of 1 µM.  5 µl of the diluted samples were added to 1 ml of assay 
mixture containing 100 mM of Na
l 
ng the 
UV-2450 PC spectrophotometer at 23 ˚C using a millimolar extinction coefficient of 18.5 
mM-1cm-1 for calculations. 10BrH2, determined 
under similar conditions in the absence of the enzyme, was subtracted during calculations 
for spe M in 
n 
t 
 0.01 
 
CcO and 1 µM cyt c.  Variable amounts of stigmatellin were added to 
oxidize
e 
 
+/K+ phosphate buffer, pH 7.4, 0.3 mM EDTA, 50 µM 
ferricytochrome c, and 25 µM Q0C10BrH2.  Activities were determined by measuri
reduction of cyt c, by following the increase in the absorbance at 550 nm, in a Shimadzu 
  The non-enzymatic oxidation of Q0C
cific activity.  Potassium cyanide was added to a final concentration of 30 µ
the assay mixture to inhibit cyt c oxidase (CcO) when determining the cyt bc1 activity i
ICM’s or chromatophores. 
 EPR experiments – The redox state of the Rieske ISP was determined by EPR 
(32) using a Bruker EMX spectrometer equipped with an Air Products flow cryostat.  Cy
bc1 complexes were diluted in 50 mM Tris-Cl, pH 8, containing 200 mM NaCl and
% DM.  The bc1 complexes were incubated with 5 mM ascorbate on ice for 30 minutes, 
and frozen in liquid nitrogen.  Cyt bc1 complexes were oxidized by overnight incubation
with 1 µM 
d bc1 complexes, and the mixture was incubated on ice for 30 minutes.  EPR 
spectra were recorded at 100 K with the following instrument settings: microwave 
frequency, 9.3 GHz; modulation frequency, 100 kHz; modulation amplitude, 6.3 G; tim
constant, 655.4 ms; and sweep time, 167.8 s.  Each spectrum represents an average of
three different traces.      
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  Isolation of Rieske ISP from R. sphaeroides bc1 complex – Wild-type cyt bc1 
complex was diluted to 50 µM cyt b in 50 mM Tris-Cl, pH 8, containing 100 mM NaC
and 0.1 % DM.  The mixture was gently shaken at 4 
l 
n 
M MgSO4 and 1 mM DTT.  The column was then washed 
 
 
 cyt 
dduct 
t at 23 oC by mixing solutions A and B in a 1:1 ratio.  Solution 
A contains 100 mM Na+/K+ phosphate buffer, pH 7.4, 1mM EDTA, 1 mM KCN, 1 mM 
oC for ninety minutes and applied to 
an octyl-sepharose column previously equilibrated with 50 mM Tris-Cl, pH 8 containing 
500 mM NaCl, 0.01 % DM and 1mM DTT.  The column was washed with 1 gel volume 
of 50 mM Tris-Cl, pH 8, 100 mM NaCl, 0.1 % DM and 1mM DTT, followed by a 
stepwise decrease in NaCl concentration to 75 mM and 50 mM.  The column was the
washed with 50 mM Tris-Cl, pH 8, 50 mM NaCl, 0.05 % DM and 1mM DTT followed 
by the same buffer containing only 0.01 % DM.  The eluates from all five washes were 
combined, and subsequently passed through a Ni-NTA column equilibrated with 50 mM 
Tris-Cl, pH 8, containing 1m
with 1 gel volume of 50 mM Tris-Cl, pH 8 containing 100 mM NaCl and 1 mM DTT. 
All eluates were combined and passed through a DEAE-Sepharose CL-6 from Pharmacia 
Biotech that was previously equilibrated with 50 mM Tris-Cl, pH 7.5, containing 0.01 % 
DM and 1mM DTT.  The column was washed with 50 mM Tris-Cl, pH 8 containing 100
mM NaCl, 0.01 % DM and 1 mM DTT.  The Rieske ISP was finally eluted with 50 mM 
Tris-Cl, containing 0.01 % DM, 500 mM NaCl and 1 mM DTT. 
 Measurement of superoxide anion generation – Superoxide generation by the
bc1 complex was determined by measuring the chemiluminescence of MCLA-O2.- a
in an Applied Photophysics stopped-flow reaction analyzer SX.18MV (Leatherhead, 
England), by leaving the excitation light off and registering light emission (33).  
Reactions were carried ou
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 N .1 % bovine serum albumin, 0.01 % DM, and 6 µM cyt bcaN3, 0 n B 
n 50 
 
 – A semi-micro assay 
as em
le 
te, and 
1 complex.  Solutio
was the same as solution A except that the cyt bc1 complex was replaced with either 50 
µM Q0C10BrH2 or 30 µM stigmatellin and 4 µM MCLA. 
 Preparation of phospholipid-deficient mitochondrial bc1 complex – Phospholipid 
and Q-depleted preparation of mitochondrial bc1 complex was prepared by means of 
repeated ammonium sulfate fractionation in the presence of 0.5 % sodium cholate i
mM Na+/K+ phosphate buffer, pH 7.4.  Cyt bc1 complex was diluted to a protein 
concentration of 10 mg/ml in 50 mM Na+/K+ phosphate buffer, pH 7.4 containing 0.5 %
sodium cholate.  Neutralized saturated ammonium sulfate solution was added to 48 % 
saturation.  After stirring for 5 minutes, the solution was centrifuged at 44000x g for 10 
minutes.  The precipitate was dissolved in 50 mM Na+/K+ phosphate buffer, containing 
0.5 % cholate.  Neutralized ammonium sulfate solution was added to 45 % saturation, 
stirred for 5 minutes followed by centrifugation at 44000x g for 10 minutes.  This process 
was repeated three more times with 40 % ammonium sulfate saturation.  The precipitate 
was finally dissolved in 50 mM Na+/K+ phosphate buffer, pH 7.4, containing 10 % 
glycerol. 
 Extraction of ubiquinone / ubiquinol from cyt bc1 complex
w ployed for extraction of ubiquinol / ubiquinone from mitochondrial and bacterial 
bc1 complexes (34).  1 ml of protein containing 2-5 mg of protein was placed in a 45 ml 
glass centrifuge tube.  Rapid addition of 4 ml cold methanol using a hypodermic need
was immediately followed by 5 ml hexane.  The mixture was vortexed for 1 minu
centrifuged for 2 minutes to separate the layers.  The upper layer of hexane was 
transferred to another glass centrifuge tube while 3 ml of hexane was added to the lower 
 73
 layer for further extraction.  After vortexing and centrifugation, the upper hexane layer 
was collected and combined with the first extraction.  The combined hexane extract was
placed in a vacuum desiccator to evaporate the hexane.  R
 
esidual lipid was dissolved in 
s.  The 
e 
rding 
li (38) using a Bio-Rad mini-protean dual slab vertical cell.     
spectroscopically pure ethanol, ubiquinone / ubiquinol was quantitated spectroscopically 
in a Shimadzu UV-2450 PC spectrophotometer. 
 Determination of Cytochrome b reduction – Reduction of cyt b was followed at 
23 °C in an SX.18MV stopped flow spectrophotometer from Applied Photophysic
reaction was started by rapidly mixing 5 µM bc1 complex in assay buffer containing 50 
mM Tris-Cl, pH 8, 200 mM NaCl, and 0.01 % DM against an equal volume of the sam
buffer containing 50 µM stigmatellin.  The reaction kinetics at 578 nm was subtracted 
from that at 560 nm to obtain the time course and amplitude of cyt b reduction induced 
by stigmatellin.      
 Other Biochemical and Biophysical Techniques – Protein concentration was 
determined by the method of Lowry et al (35).  Cyt b (36) and cyt c1 (37) concentrations 
were determined according to published methods.  SDS-PAGE was performed acco
to Laemel
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 RESULTS AND DISCUSSION 
 
Stigmatellin-induced reduction of the Rieske Iron-Sulfur Cluster – The EPR 
spectrum of the reduced iron-sulfur cluster (ISC) of the Rieske protein shows rhombic 
symmetry with three characteristic g values; gz = 2.02, gy = 1.89 and gx = 1.80 (39).  In 
e pre
y 
 
 
n 
atellin (data not shown).  Complete oxidation of the cyt bc1 complex 
efore PR 
he cyt bc1 
complex increases its redox midpoint potential from +290 mV to +540 mV (40).  
Moreover, stigmatellin arrests the head domain of ISP at the ‘fixed’ or b-position, 
proximal to cyt b, as derived from the anomalous diffraction signals whereby the mobility 
of the ISC is dramatically reduced (9).  Fig. 19A shows the ubiquinol-cyt c reductase 
activity of R. sphaeroides bc1 complex in the presence of varying amounts of 
stigmatellin.  Stigmatellin inhibits the complex with a stoichiometry of 0.5 mole inhibitor 
per mole (monomer) bc1 complex.  Similar stoichiometric values have been demonstrated  
th sence of ascorbate, the EPR spectrum of the cyt bc1 complex from Rhodobacter 
sphaeroides displays the characteristic g values signaling ISC reduction (Fig. 18, trace 
A).  Interestingly, the addition of stigmatellin to R. sphaeroides bc1 complex, oxidized b
incubation overnight with enzymatic amounts of cyt c oxidase (CcO) and cyt c, results in
reduction of the ISC in the absence of an apparent electron source (trace B).  Reduction
of the ISC is also observed in oxidized cyt bc1 complexes from bovine mitochondria upo
the addition of stigm
b the addition of stigmatellin is confirmed by the absence of the characteristic E
signals of reduced ISC (trace C). 
Stigmatellin contains a 5, 7-dimethoxy-8-hydroxychromone system with a 
hydrophobic alkenyl chain at position 2 (29).  Binding of stigmatellin to t
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 Figure 18.  EPR spectra of wild-type Rhodobacter sphaeroides bc1 complex.  Th
minutes and subsequently frozen in liquid nitrogen (A).  Cytochrome bc
e bc1 
complexes (100 µM cytochrome b) were incubated with 5 mM ascorbate on ice for 30 
es were 
oxidized by overnight incubation with 1 µM cytochrome c oxidase and 1 µM cytochrome 
mplex 
only (C).  EPR spectra were recorded at 100 K with the following instrument settings: 
6.3 G; time constant, 655.4 ms; and sweep time, 167.8 s.  Each spectrum represents the 
1 complex
c before 200 µM stigmatellin was added to the bc1 complex (B).  Oxidized bc1 co
microwave frequency, 9.3 GHz; modulation frequency, 100 kHz; modulation amplitude, 
average of three separate traces.       
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 in cyt bc1 complexes from yeast (41) and in submitochondrial particles (40).  This 
indicates that the binding of stigmatellin to only one monomer per dimer is sufficient to 
abolish bc1 complex activity.  Binding also exhibits negative co-operativity; i.e. 
stigmatellin binds to a monomer of every inhibitor-free dimer before it binds to the 
second monomer (41).  It must be noted negative co-operativity does not imply that 
stigmatellin is unable to bind to a monomer where stigmatellin is bound to the other 
monomer; i.e. negative co-operativity is not absolute.  It simply means that the binding or 
‘ON’ rate of the stigmatellin molecule for the monomer in the inhibitor-free dimer is 
much greater than for a monomer whose interacting monomer already has a bound 
stigmatellin molecule.  ISP reduction induced by stigmatellin binding to oxidized bc1 
complex titrated against varying concentrations of the inhibitor is shown in Fig 19B.  
Maximal reduction of the ISC by stigmatellin is obtained at a stoichiometry of 1 inhibitor 
per bc1 complex monomer indicating that binding to every monomer is necessary for 
complete ISC reduction.  Similarly, one molecule of stigmatellin per bc1 complex 
monomer was required to obtain maximal spectral shift of the dithionite-reduced cyt b 
(40).  The binding of stigmatellin to the cyt bc1 complex elevates the mid-point potential 
of the Rieske ISP, thereby generating a strong electron sink which results in the observed 
reduction of the ISC in the absence of an apparent electron source.   
It is possible that the 8-hydroxy group of the chromone ring system of 
stigmatellin directly reduces the ISC.  This possibility is investigated by adding 
stigmatellin to pure Rieske ISP isolated from R. sphaeroides bc1 complex (Fig. 20A).  
Rieske ISP was isolated in the presence of dithiothreitol (DTT) since the ISC is easily 
lost, when it is not in the reduced state, during the isolation from the bc1 complex.  The  
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Figure 19.  Inhibition of ubiquinol-cytochrome c reductase activity (A) a
reduction (B) of the Rieske iron-sulfur cluster of oxidized bc1 complexes by vary
amounts of stigmatellin.  For specific activity measurements, cyt bc1 complex 
diluted to 1 µM cyt b in 50 mM Tris-Cl, pH 8 containing 200 mM NaCl and 0.01 % D
Stigmatellin was added in varying amounts to the enzyme complex and the mixture was 
incubated on ice for 20 minutes before collection of data.  For determining reduction of 
the Rieske ISP, the bc1 complexes were diluted to 100 µM cyt b in 50 mM Tris-Cl, pH
containing 200 mM NaCl and 0.01 % DM before addition of stigmatellin.  The mixture 
was incubated on ice for 15 minutes and subsequently frozen in liquid nitrogen
extent of ISP reduction induced by addition of varying amounts of stigmatellin was
determined by the intensity of the gy EPR signal.  Sample preparations and instrume
settings were the same as in Fig. 18.   
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 EPR spectrum of isolated ISP was recorded in the presence of either stigmatellin or 
ascorbate (Fig. 20B).  In the presence of ascorbate, the characteristic EPR spectrum for 
the reduced Rieske ISP with its distinct g values is observed indicating that the ISC is not 
lost during the purification of the ISP from the cyt bc1 complex.  The gx signal of the 
isolated Rieske ISP is broad with g = 1.75 - 1.77.  Similar broadening of the gx signal has 
been reported in bc1 complexes with either an empty QP site, with reduced ubiquinol 
present or in the presence of an MOA inhibitor (40).  Addition of stigmatellin to oxidized 
ISP does not show any reduction of the ISC as evidenced by lack of the characteristic 
PR signals (Fig. 20).  Therefore, stigmatellin itself does not reduce the ISC directly, but 
ammonium acetate fractionation (43).  Delipidation of mitochondrial bc1 complexes 
results in the loss of ubiquinol-cyt c reductase activity, but reconstitution with exogenous 
phospholipids restores a significant amount of the inhibitor-sensitive activity (data not 
shown).  The EPR spectrum of phospholipid-deficient bc1 complex in the presence of 
stigmatellin shows no ISC reduction as evidenced by the silent g values while ISC 
reduction is observed in the presence of ascorbate (data not shown).  This indicates that 
stigmatellin is unable to induce ISC reduction in phospholipid-deficient cyt bc1 
complexes.  However, incubation of the phospholipid-deficient cyt bc1 complex with  
E
upon binding to the bc1 complex induces electron transfer to the ISC.  Stigmatellin, like 
other Pf inhibitors of the cyt bc1 complex does not bind to isolated Rieske ISP but binds 
to cyt b subunit at the QP site proximal to ISP and distal from heme bL (42).  
 The necessity of stigmatellin binding to the cyt bc1 complex for ISC reduction is 
further evaluated in phospholipid-deficient bovine cyt bc1 complexes where 90 % of 
phospholipids and ubiquinone/ubiquinol molecules are removed by repeated cholate-
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Figure 20.  Characterization of purified Rieske ISP isolated from R. sphaeroides bc1 
led 
under “Experimental Procedures”, and was subjected to SDS-PAGE (A).  The purified 
 0.4 % 
β-mercaptoethanol at 23 °C for 15 minutes before loading into the gel.  Protein standard 
3 
kDa), ovalbumin (53.5 kDa), carbonic anhydrase (37.2 kDa), soybean trypsin inhibitor 
e isolated 
ISP in the presence of stigmatellin (upper trace) and ascorbate (lower trace) were 
 
 
 
 
 
complex.  Rieske ISP was isolated from the cytochrome (cyt) bc1 complex as detai
Rieske ISP (lane 3) and cyt bc1 complex (lane 2) was digested with 1 % SDS and
contains: myosin (195 kDa), β-galactosidase (115.6 kDa), bovine serum albumin (97.
(29.4 kDa), lysozyme (20.4 kDa), and aprotinin (6.92 kDa).  EPR spectra of th
recorded (B).  Instrument settings were as described in Fig. 18. 
A 
B 
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 azolectin, phospholipids from soybean, before adding stigmatellin restores a significant 
am onstrates that phospholipids are 
essential for the binding of lex, and correct binding is 
necessary for the stigma
ubiquinol can effectively be ruled out as the electron source for ISP reduction induced by 
stigma ented, ubiquinol-
deficient mitochondrial 
 is possible that the Tris (2-amino-2-(hydroxymethyl)-1, 3-propanediol) buffer 
system ectrons for the Rieske 
ISC in the p C is  
lso observed in bc1 complexes purified using Na+/K+ phosphate buffer system, thereby 
nambiguously eliminating the –OH groups of Tris as possible source of electrons (data 
ot shown).   
Characterization of Free Radicals Generated by the Cyt bc1 Complex in the 
resence of Stigmatellin or Ferricyanide – In addition to reduction of the Rieske ISC, an 
PR peak with a symmetrical line shape, and g value centered at g = 2.005, typical 
haracteristics of an organic free radical is observed when stigmatellin is added to 
xidized cyt bc1 complex.  The intensity of the g = 2.005 EPR signal increases with 
tellin is added to the cyt  
ount of the ISC reduction (data not shown).  This dem
 stigmatellin to the cyt bc1 comp
tellin-induced ISC reduction.  Furthermore, endogenous 
tellin, since ISP reduction is observed in phospholipids-supplem
bc1 complex.  
It
 used during purification of the bc1 complex provides the el
resence of stigmatellin.  However, stigmatellin reduction of the Rieske IS
a
u
n
P
E
c
o
varying amounts of stigmatellin (Fig. 21).  Stigmatellin increases the midpoint potential 
of the Rieske ISP by approximately 260 mV to 540mV, resulting in the generation of a 
strong oxidizing agent.  Because of its acquired oxidative nature, we speculate that the 
Rieske ISC extracts an electron from nearby organic residues, leading to its reduction and 
the subsequent generation of organic free radicals.  When stigma
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Figure 21.  Effect of ferricyanide or stigmatellin concentration on the g = 2.00
1
containing 200 mM NaCl and 0.01 % DM.  Stigmatellin (-○-) and ferricyanide (-●-) 
minutes before being frozen in liquid nitrogen.  Instrument settings were as described in
 
 
 
 
5 EPR 
signal.  Cytochrome bc  complex was diluted to 50 µM in 50 mM Tris-Cl, pH 8, 
were 
added to the desired concentrations, and the mixtures were incubated on ice for 15 
 
Fig. 18. 
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 bc1 complex at molar concentrations of 15 or higher, the mixture turns turbid due to 
Since a symmetrical g = 2.005 EPR signal is often attributed to a 
the inhibitor, antimycin A, and can thus be distinguished from other organic radicals (44) 
of the cyt bc1 complex.  Pre-treatment of the bc1 complex with antimycin A prior to 
stigmatellin addition reduces the intensity of the g = 2.005 signal by approximately 30 % 
(Fig 22).  This indicates that the vast majority of organic radicals generated upon the  
partial precipitation of the bc1 complex.  It is speculated that excessive oxidation of 
organic residues induced by the high potential Rieske ISC eventually leads to 
denaturation and unfolding of the native enzyme.  Addition of ferricyanide, a strong 
oxidant (Em ~ 420mV), to oxidized cyt bc1 complex also results in generation of the g = 
2.005 EPR signal (Fig 21).  Radical production increases with increasing concentrations 
of ferricyanide.  When ferricyanide is added at a 10 to 15-fold molar excess of bc1 
complex, the g = 2.005 signal shows saturation indicating that possible oxidizable 
residues in the bc1 complex become limiting.  Moreover, it is speculated that ferricyanide 
might begin oxidizing some of the generated organic radicals resulting in quasi-
equilibrium between oxidation of both organic residues and organic radicals.  It must be 
noted that the amount of radicals produced in the ferricyanide-treated complex is 
approximately ten-fold greater than that observed in the presence of stigmatellin.  
Ferricyanide oxidation of organic residues directly proportional to the concentration used 
whereas stigmatellin induced oxidation is dependant on the amount of ISC available. 
  
ubisemiquinone radical at the QN site upon the reduction of ubiquinone by heme bH (20), 
it is of interest to determine whether the stigmatellin induced radical is the same as QN 
radical or not.  The ubisemiquinone anion generated at the QN site is entirely sensitive to 
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Figure 22.  Characterization of the g = 2.005 EPR signal in wild type cytochrome bc1
8, containing 200 mM NaCl and 0.01 % DM, and oxidized by overnight incubation in the 
oxidized complex treated with 500 µM stigmatellin, curve with filled circles (-●-) 
500 µM stigmatellin plus 5 mM ascorbate.  Instrument settings were as described in Fig.
18. 
 
complexes.  Cytochrome (cyt) bc1 complex was diluted to 50 µM in 50 mM Tris-Cl, pH 
presence of 1 µM cyt c oxidase and cytochrome c.  Curve with open squares (-□-) shows 
is for 
250 µM antimycin A plus 500 µM stigmatellin and curve with open circles (-○-) is for 
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addition of stigmatellin to the cyt bc1 complex can be attributed to antimycin A-
insensitive organic radicals.  Moreover, in the presence of ascorbate, an 85 % decrease in 
bc
inf
the Q-radical at the QN site.  
superoxide generated in mitochondria (47-50).  Superoxide (O2.-) production, detected as  
the g = 2.005 EPR signal of stigmatellin-treated complex is observed (Fig. 22).  
Ascorbate likely donates an electron and reduces the organic radicals formed in the 
stigmatellin-treated complex, resulting in a substantial decrease of the g = 2.005 EPR 
signal.  To further demonstrate the organic radicals generated by the addition of 
stigmatellin to the complex are different from the ubisemiquinone radical at the QN site, 
power saturation profiles are determined (Fig 23).  The g = 2.005 signal produced when 
1 complex is treated with stigmatellin is monophasic and shows saturation at 
approximately 0.420 mW.  The QN radical in the ascorbate-treated wild-type bc1 complex 
shows saturation at approximately 0.211 mW.  Similar power saturation at 0.251 mW has 
been previously reported for the QN radical generated in mitochondrial bc1 complex (45).  
The power saturation profiles of the two free radical species indicate differences in the 
interactions with paramagnetic cofactors in the aqueous milieu, and also provide 
ormation on the relative location of the radical species within the enzyme complex.  
The significant difference in the power saturation properties confirms that the organic 
radical generated in the cyt bc1 complex in the presence of stigmatellin is different from 
Production of superoxide in cyt bc1 complexes treated with stigmatellin – 
Approximately 1-2 % of oxygen consumed during normal respiration is not involved with 
oxidative phosphorylation, but with the formation of superoxide (46). Complex I and 
Complex III (bc1 complex) were identified as two segments responsible for much of the 
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Figure 23.  Power saturation properties of the g = 2.005 EPR signal.  Pow
saturation of the free radical signal generated in the cytochrome (cyt) bc
er 
on 
of 
-
 
a  on ice for 20 minutes prior to freezing in liquid nitrogen.  
 me as in Fig. 18 except various microwave powers were 
used.  
1 complex up
treatment with stigmatellin is shown as open squares (-□-) and in the presence 
ascorbate as open circles (-○-).  Cyt bc1 complexes were diluted to 50 µM in 50 mM Tris
Cl, pH 8, containing 200 mM NaCl and 0.01 % DM, and incubated with either 500 µM
stigmatellin or 5 mM ascorb te
Instrument settings were the sa
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 the fluorescence of 6-(4- methoxyphenyl)-2-methyl-3,7-dihydroimidazo[1,2-a] pyrazin-3 
of stigm
comp
stigm
Rieske ISP that lacks the ISC (51).  In the presence of ubiquinol, O2.- production is 
electron transfer at the QP site preventing the formation of the two individual species 
responsible for O2.- production.  Similarly, addition of stigmatellin to the mutant bc1 
complex does not generate any O2.- (Fig 25B), although the mutant bc1 complex is able to 
bind stigmatellin as evidenced by the red-shift in the absorption of reduced cyt b (data not  
(7H) – one hydrochloride (MCLA) - O2.- adduct, is observed upon adding the substrate, 
ubiquinol, to the bc1 complex (Fig 24, trace A).  Addition of stigmatellin in the absence 
of ubiquinol also generates O2.- (trace B), and its production is dependant on the amount 
atellin added.  Similarly, when ferricyanide is added to the bc1 complex, O2.- is 
generated (trace C).  However, the rate of fluorescence decay is much more rapid as 
ared to the O2.- formed in the presence of either ubiquinol or stigmatellin possibly 
due to alterations in the ionic strength of the radical environment.  In the presence of 
superoxide dismutase (SOD), O2.- is not observed when either ubiquinol or stigmatellin is 
added to the wild-type bc1 complex, confirming the production of O2.- as a byproduct of 
the reaction (trace D).  It is speculated that the O2.- is generated as a result of the 
interaction between molecular oxygen and the organic free radicals generated in the 
atellin and ferricyanide treated bc1 complex.  To further demonstrate this 
speculation, O2.- generation is measured in the double mutant, H131N / H152N, in the 
observed in the wild-type, but not in the mutant complex (Fig. 25A).  In the normal 
catalytic cycle of the cyt bc1 complex, ubisemiquinone radical at the QP site (47), and 
reduced cyt b566 (48) are postulated to be the auto-oxidizable factors causing superoxide 
production.  Absence of the Rieske ISC in the mutant complex abolishes the bifurcated 
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Cytochrome bc1 was diluted to 6 µM cytochrome b and superoxide production w
ferricyanide (C), or 60 µM stigmatellin in the presence of superoxide dismutase (D)
o
reaction analyzer SX18MV as described in “Experimental Procedures”. 
Figure 24.  Superoxide generation in wild-type cytochrome (cyt) bc1 complex.  
as 
determined upon addition of 50 µM ubiquinol (A), 60 µM stigmatellin (B), 60 µM 
.  
Superoxide generation was measured at 23 C in an Applied Photophysics stopped-flow 
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Figure 25.  Superoxide generation in mutant lacking the Rieske iron-sulfur cluster.
Tracings of superoxide generation in 6 µM wild-type and mutant (∆ 2Fe-2S) cytochrome
bc1 complexes in the presence of 50 µM ubiquinol (A) or 60 µM stigmatellin (B).
Curves with open circles (-○-) denote the wild type complex while curves with closed
circles (-●-) represent the mutant complex.  Sample preparation and instrument settings 
were as described in Fig. 24. 
A B 
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 shown).  Binding of stigmatellin to the ISC-deficient mutant complex does not result in 
e ration of a strong oxidizing agent, i.e. a Rieske ISC with a highly elevated 
duce the extraction of an electron from an organic residue by the Rieske ISC. 
herefore, organic radicals are not generated, and no electron source is available for 
olecular oxygen to form O2.-. 
Cyt b reduction in bc1 complexes treated with stigmatellin or ferricyanide – 
ddition of stigmatellin to the fully oxidized bc1 complex results in slow reduction of cyt 
 (Fig 26, trace A).  Similarly, when ferricyanide is added to the oxidized complex, cyt b 
observed cyt b reduction.  Moreover, addition of stigmatellin to a mutant complex 
lacking the Rieske ISC does not show any reduction of cyt b (trace D).  The absence of 
the ISC in the mutant complex prevents the formation of a strong oxidizing agent; 
subsequently no organic radicals capable of reducing cyt b are generated.  However, in 
the presence of ferricyanide, cyt b reduction is detected in the mutant complex.  Unlike 
with stigmatellin, the generation of organic radicals by ferricyanide is independent of 
ISC, thereby explaining the observed cyt b reduction.  It must be noted that the extent of 
cyt b reduction in the mutant is lower than the complement wild-type complex.  Altered 
accessibility of oxidizable residues as a result of possible conformational changes 
induced by the mutation could account for this decrease.  One of the strongest supports 
for divergent electron flow at the QP site specified by the Q-cycle is the phenomenon of         
th  gene
midpoint potential.  Consequently, stigmatellin binding to the mutant complex does not 
in
T
m
A
b
reduction is observed with rates and extent comparable to the stigmatellin treated 
complex (trace B).  Organic radicals, generated upon extraction of an electron by the 
Rieske ISC in stigmatellin-treated complexes or ferricyanide, are responsible for the 
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Figure 26.  Characterization of cytochrome (cyt) b reduction.  Fully oxidized wil
% DM, and cyt b reduction was measured upon addition of 50 µM stigmatellin (A) an
ISC upon addition of ferricyanide (C) or stigmatellin (D) was also determined. 
d-
type cyt bc1 complex was diluted to 5 µM in 50 mM Tris-Cl, pH 8, 200 mM NaCl, 0.01 
d 
ferricyanide (B) respectively.  Cyt b reduction in a mutant complex lacking the Rieske 
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‘oxidant-induced reduction of cyt b’ (52).  Oxidation of the high potential chain, 
including cyt c1 and ISP, results in a transient increase in cyt b reduction that is driven by 
the ubisemiquinone species generated at the QP site.  Perhaps part of the cyt b
in the presence of an oxidant, comes from oxidized organic radicals, as dem
above.  
In conclusion - The Rieske ISP is in the fixed ‘b’ position when stigma
the cyt bc1 complex.  As a result, the redox mid-point potential of the Rieske ISP 
increases by 250 mV creating a strong oxidant.  This elevated redox pot
as the driving force for electron transfer from organic residues to the oxidized Rieske ISC 
resulting in its reduction, and the subsequent generation of organic radicals.  The organic 
radicals in turn can react with molecular oxygen to yield O2.- or donate an electron to cyt 
b.  The generation of organic radicals by stigmatellin-treated cyt bc1 comple
retarded upon addition of ascorbate whereby the organic radicals are neutralized.  
 reduction, 
onstrated 
tellin is added to 
ential thus serves 
x is severely 
e generation of organic radicals, subsequent 
duction.  
Finally, stigmatellin-induced reduction of the oxidized Rieske ISP might be used to 
identify cyt bc1 mutations that confer resistance to the inhibitor, in addition to causing a 
red-shift in the cyt b absorption spectrum.  
 
 
Ferricyanide, a strong oxidant, also induces th
formation of O2.- and reduction of cyt b.  O2.- is not observed in cyt bc1 mutant complexes 
lacking the Rieske [2Fe-2S] cluster providing further evidence that the elevated mid-
point potential of the Rieske ISC drives the reduction of the ISC and radical pro
 92
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PTER IV 
) – ISP reduction by ascorbate in bc1 
p gy 
EPR ce of stigmatellin (Fig. 27).  
l
Stigm Em from 
differ s 
incre e 
solub domain of ISP is partitioned equally between a fixed and 
specu
positi  are reduced.  This hypothesis is 
b).N3 lently fixed onto 
ytochrome b by a pair of genetically engineered disulfide bonds, effectively mimicking 
e stigmatellin-bound state.  Adduct protein bands with apparent molecular masses of 64 
nd 128 kDa respectively, the size of one cytochrome b and one ISP and two  
 
CHA
 
UNPUBLISHED WORKS 
EPR spectra of iron sulfur protein (ISP
com lexes, purified using the Tris buffer system and quantitized by the intensity of the 
signal, is only 50 % of that observed in the presen
Simi ar observations are made when the bc1 complex is reduced with dithionite.  
atellin arrests both Rieske ISP’s in the fixed ‘b’ position, and elevates its 
+280 mV to +540 mV.  The iron sulfur cluster (ISC) peak heights in anomalous 
ence maps normalized to the heme bH peak is 0.47 for native bc1 complexes, and i
ased to 1.18 upon treatment with stigmatellin.  In the native, inhibitor-free state, th
le extra-membrane head 
loose state, while it is entirely in the fixed state in the presence of stigmatellin.  We 
late that ascorbate reduces only one of the Rieske ISP’s, those in the fixed ‘b’ 
on, thereby explaining why only 50 % of the ISP’s
further analyzed in a R. sphaeroides bc1 complex mutant (K70C (ISP)/A185C (cyt. 
6C (ISP)/G89C (cyt. b) whose soluble ISP head domain is cova
c
th
a
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purified in 50 mM Tris-Cl, pH 8, 200 mM NaCl, 0.5 % DG and 200 mM histidine, were 
te 
(A) or 350 µM stigmatellin (B) and incubated on ice for 20 minutes before freezing in 
. 18.   
 
 
 
 
 
 
Figure 27.  EPR spectra of bc1 complex in Tris buffer.  Cytochrome bc1 complexes,
diluted to 70 µM cytochrome b.  The bc1 complexes were treated with 5 mM ascorba
liquid nitrogen.  Sample preparations and instrument settings were the same as in Fig
 101
  cytochrome b’s and two ISP’s respectively,  are detected when the mutant bc1 complex is
plex, as
determined by the intensity of the g = 1.89 EPR signal, is approximately two-fold higher 
than observed in the wild type complex (Fig. 28, left panel).  In the presence of 
stigmatellin, the extent of ISP reduction in the wild type and mutant complexes are
similar (Fig 28, right panel) indicating complete ISP reduction.   
Cytochrome (cyt) bc1 complexes were purified from Rhodobacter sphaeroides 
using the following buffer: 50 mM Tris-Cl, pH 8, containing 200 mM NaCl and 200 mM 
histidine.  It has been well established that the pH of Tris buffer is sensitive to 
temperature, showing a 0.03 unit change in pH per degree change in temperature.  Cyt 
bc1 complexes are frozen in liquid nitrogen (approx -200 °C) prior to determining the 
redox state of ISC, and similarly, EPR data is collected at liquid nitrogen temperatures.  
increasing pH and vice versa.  It is possible that the redox potential of ISP in Tris buffer 
is lowered where it is not readily reducible by ascorbate at liquid nitrogen temperatures.  
To test this speculation, EPR spectra were recorded for bc1 complexes solubilized in 50 
mM Na+/ K+ phosphate buffer, pH 8, containing 200 mM NaCl, 0.5 % DG and 5 mM 
histidine (Fig. 29).  The intensity of the g = 1.89 EPR signal in the presence of ascorbate 
or stigmatellin is comparable to one another, indicating total reduction of the Rieske ISP 
in the ascorbate-treated complex.  The pH of phosphate buffer is not dependant on 
 
treated with SDS and subjected to electrophoresis in the absence of β-mercaptoethanol 
(data not shown).  The extent of ISC reduction by ascorbate in the mutant bc1 com  
 
Such low temperatures undoubtedly lead to large increase in pH of the Tris buffer system 
containing the bc1 complex samples, although an exact value is difficult to quantitize.  
The redox potential of ISP, +280 mV at pH 8, is pH-dependant; it decreases with 
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Figure 28.  EPR spectra of mutant K70C (ISP) / A185C (cyt. b) N36C (ISP)/G89
(cyt. b).  EPR spectra of WT (traces A) and the mutant complex (traces B)in the presen
of ascorbate (left panel) and stigmatellin (right panel) were recorded.   Ascorbate 
stigmatellin were added to 70 µM bc
. C 
ce 
and 
50 
n 
1 complex to a final concentration of 5 mM and 3
µM respectively.  The mixtures were incubated on ice for 20 min prior to freezing i
liquid nitrogen.  EPR instrument settings are the same as in Fig. 18.  
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 temperature, and consequently the redox potential of Rieske ISP is unaffected when the 
complete demonstrates that ascorbate reduc
head domain since ISP’s in both the fixed and m
It was thus necessary to determine why 
complex in Tris buffer was only half of that
treated mutant complex with its ISP head dom
We speculate that the redox potential of
location of the mobile head domain.  When the 
e redox potential is enhanced, since this is in the natural state for receiving an electron 
speculate that the drop in redox potential of ISP as a result of the lowered temperature 
results in a dramatic lowering of the ISP redox potential.  The redox potential of ISP in 
the ‘loose’ state, which we ascertain is lower than the fixed state, falls below the 
threshold where it is no longer reducible by ascorbate.  This explains why only 50 % of 
the ISP in Tris buffer is reduced by ascorbate.  The mutant with the ISP head domains 
tethered to cytochrome b has ISP’s with elevated redox potential by virtue of their 
position.  The redox potential drop of ISP in mutant complexes in Tris buffer is not 
sufficient to prevent reduction by ascorbate.  A similar argument can be made for 
stigmatellin treated bc1 complexes in Tris buffer.  Moreover, it is well known that 
stigmatellin raises the redox potential of ISP by a factor of about two.  Assumptions can  
samples are frozen in liquid nitrogen.  The fact that ISP reduction in phosphate buffer is 
tion is not governed by the location of the 
obile states were reducible by ascorbate.  
ascorbate reduction of ISP in wild type bc1 
 observed in phosphate buffer, or ascorbate-
ains tethered to cyt b.     
 ISP varies, and is governed by the 
ISP head domain is in the fixed ‘b’ state, 
th
from the substrate, ubiquinol.  On the contrary, the redox potential of the ISP in the 
‘loose’ state is lowered possibly to facilitate electron transfer to cytochrome c1.  
Therefore, when wild-type bc1 complex in Tris buffer is frozen in liquid nitrogen, we 
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Figure 29.  EPR spectra of bc1 complex purified in Na /K  phosphate buffer.  
d 
200 mM histidine was dialyzed in 100x volume of 50 mM Na /K  phosphate buffer, pH 
 of 
buffer.  EPR spectra of bc1 complex (70µM cyt b) in the presence of 5 mM ascorbate (A) 
e as in 
Fig. 18. 
 
 
 
 
 
 
+ +
Cytochrome bc1 complex purified in 50 mM Tris-Cl, pH 8, 200 mM NaCl, 0.5 % DG an
+ +
8, 200 mM NaCl, 0.5 % DG and 5 mM histidine for four hours, with two changes
and 350 µM stigmatellin (B) were recorded. EPR instrument settings were the sam
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 be made that the redox potential of ISP in the mutant complex increases by a similar 
anner.   
Our experimental data indicate that the redox potential of the Rieske ISP 
en it is in the 
 
electron transfer to cytochrome c1.   
 
Identifying amino acid residues that donate an electron to oxidized ISP in th
presence of stigmatellin – As shown in Chapter III, stigmatellin induces reduction of the 
Rieske ISP in oxidized bc1 complexes in the absence of an apparent electron source.  It 
was shown that the elevated redox potential of the ISP upon stigmatellin binding res lted 
in ISP being a strong oxidant, extracting an electron from an organic residue resulting in 
its reduction and organic radical formation.  Amino acid residues capable of donating an 
electron include tyrosine, threonine, serine, phenylalanine, histidine, cysteine and 
ethionine.  Oxidized cytochrome bc1 complexes pre-treated with NEM, a cysteine 
stigmatellin, several amino acid residues were altered by site-directed mutagenesis.  The 
premise of our hypothesis was rather straight-forward:  if a particular amino acid residue 
was responsible for ISP reduction in the presence of stigmatellin, then mutation of this 
residue would eliminate this observation.  Unfortunately, attempts to identify specific 
m
undergoes drastic changes during the catalytic cycle of the bc1 complex.  Wh
fixed ‘b’ state, the potential is highly elevated to facilitate electron transfer from 
ubiquinol.  When ISP is in the mobile ‘loose’ state, its potential is lowered to facilitate
e 
u
m
modification agent, prior to addition of stigmatellin resulted in the reduction of ISP.  This 
indicates that cysteine residues within the bc1 complex are not the electron source for ISP 
reduction.  To identify residues that possibly donate an electron to ISP in the presence of 
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 amino acid residues responsible for ISP reduction were unsuccessful.  A compilation 
mutations 
of 
generated for this purpose is listed in Table 5. 
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  Table 5 
 
Mutants generated to identify amino acid residues responsible for ISP reduction in 
oxidized bc1 complexes treated with stigmatellin 
 
 
(CYT b) 
            Mutation (R. sphaeroides numbering) 
 Y302A C145A  Y156F 
 Y302C      Y156A 
 Y302F C169A   
 
 E295K S154A 
 E295G      S154C  
 E295T 
 
 Y147A 
 
 H291A 
 
 T288A 
 
 Y280A 
(CYT c1) ISP 
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